Pediatric Healthcare Market By Offering (Drugs (General Anaesthetics & Oxygen, Pain & Palliative Care, Antiallergics, Antidotes, Anticonvulsants/ Antiepileptics, Anti-Infective Medicines (Anthelminthics, Antibacterial, Antifungal Medicines, Antiviral Medicines, Antiprotozoal Medicines, & Others), Antimigraine Medicines, Immunomodulators & Antineoplastics, Medicines Affecting the Blood (Antianaemia Medicines, Coagulation, etc.), Cardiovascular Medicines, Dermatological Medicines, Disinfectants & Antiseptics, Gastrointestinal Medicines, Endocrine Disorders Medicines, Immunologicals, & Others (Diagnostic Agents, Respiratory Tract Medicines, Etc.)) Devices/Equipment (In Vitro Diagnostic (IVD) Devices, Diagnostic Imaging Devices, Anesthesia & Respiratory Care Devices, Cardiology Devices, Orthopaedic Devices, Telemedicine, Monitoring Devices (Blood Pressure, Pulse Oximetry, Temperature Monitoring, & Others) & Others), Services (Pediatric Surgical Services, Nursing Services, Pediatric Therapy (Speech Therapy, Physical Therapy, & Others), and Others); By Application (Neonates (Below 28 days), Infants (29 days to less than 2 years), Children (2 years to less than 12 years), and Adolescents (12 years to less than 21 years)); By Distribution Channels (Online and Offline (Pharmacy & Drug Stores, Specialty Stores, Hospitals & Clinics, & Others)); By Region (North America (U.S., Canada, Mexico, & Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden & Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), & Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore & Rest of Southeast Asia), & Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, & Rest of Middle East & Africa) Latin America (Brazil, Argentina, & Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Pediatrics is defined as a branch of medicine that deals with the medical care of infants and children. The age limit in the context of pediatric healthcare, usually ranges from birth up to 21 years of age. Pediatric healthcare mainly encompasses drugs, vaccines, services and equipment. The purpose of pediatric healthcare is to save children from chronic ailments and help them to grow up healthy. Millions of children die from chronic diseases, malnutrition, and diseases caused by virus each year. The major factors contributing to the growth of global pediatric healthcare market, are a rise in the number of deaths due to various ailments, viral infections, and increasing incidences of malnutrition each year. Increasing the count of the patient and higher government efforts to raise awareness about pediatric healthcare are also contributing to the market growth. In November 2018, the United Nations Children's Fund (UNICEF) reported that about 3 million deaths occurred due to pediatric pneumonia worldwide. Other factors contributing to the market growth include emergence of home healthcare as an economical alternative to hospital services, improving life expectancy of premature infants, and increased research activities in technological advancements in the healthcare sector.
Limited availability of pediatric drugs directly catering to the specific health requirement of the given child age group is restraining the growth of global pediatric healthcare market. However, various companies and regulatory bodies are spending heavily on R&D activities to explore and introduce new drugs as well as more efficient medical devices, which is anticipated to proliferate the market growth over the future years. For instance, electronic health records (EHR) vendor Cerner Corporation co-hosted a digital health accelerator event to boost health information technology (IT) innovation for pediatric care. Cerner Corporation held the first annual Bear Institute Pediatric Accelerator Challenge for Kids (PACK) with the Bear Institute and Children’s National Hospital in August 2021. The partnership between these entities is meant to address the funding gap in digital health innovation for pediatric care.
Due to China-originated coronavirus infection surge all over the world, the global medical infrastructure, especially the life-saving health services, is facing serious burden. Digitization in the healthcare sector has served as a major boon to the global pediatric healthcare market. Healthcare professionals and parents are largely relying upon telemedicine and telehealth services to obtain diagnosis and treatment services for their children. For instance, it was reported that by March 2020, telemedicine for children with medical complexity had increased during this period. As physician visits were restricted during the pandemic, virtual visits for patient care are witnessing increased demand and showcases substantial growth opportunities for global pediatric healthcare market over the forecast period. Furthermore, government policies aimed at infant healthcare will present new opportunities for business expansion for existent as well as new entrants in the global pediatric healthcare market.
In terms of revenue, pediatric healthcare market was valued at more than US$ 90 Bn in 2020 growing at a CAGR of 5.1% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Pediatric Healthcare Market Revenue & Forecast, (US$ Million), 2015 – 2029
Offering Outlook:
In the context of offering, the global pediatric healthcare market has been primarily segmented into drugs, devices, and services. The drugs segment has been further segmented into general anaesthetics & oxygen, pain & palliative care, antiallergics, antidotes, anticonvulsants/ antiepileptics, anti-infective medicines, antimigraine medicines, immunomodulators & antineoplastics, medicines affecting the blood (antianaemia medicines, coagulation, etc.), cardiovascular medicines, dermatological medicines, disinfectants & antiseptics, gastrointestinal medicines, endocrine disorders medicines, immunologicals, and others. The anti-infective medicines category has been further segmented into anthelminthics, antibacterials, antifungal medicines, antiviral medicines, antiprotozoal medicines, and others. The devices category has been further segmented into in vitro diagnostic (IVD) devices, diagnostic imaging devices, anesthesia & respiratory care devices, cardiology devices, orthopedic devices, telemedicine, monitoring devices, and others. The services category has been further segmented into pediatric surgical services, nursing services, pediatric therapy, speech therapy, physical therapy, and others.
The drugs segment accounted for the largest market share in 2020. Anti-infectives is a general term that is used to describe any medicine that inhibit the spread of an infectious organism or kills the infectious organism. This term encompasses antibiotics, antifungals, antimalarials, anthelmintics, antiprotozoals, antituberculosis agents, and antivirals.
Antivirals are medications help the patient's body to fight off certain viruses that can cause disease. Antiviral drugs are also preventive. They can boost the immunity and protect patient from getting viral infections or spreading the virus to others. In September 2021, the Central Drug Research Institute (CDRI) concluded that the clinical trials of antiviral drug, Umifenovir, in treatment of COVID-19, have been a successful exercise. The drug was tested on 132 coronavirus patients. By checking multiplication of the virus, the drug effectively reduced the viral load to zero in asymptomatic patients or mild or moderate symptomatic patients.
Antiprotozoal drugs are used to treat infections caused by protozoa. In August 2020, the FDA of USA approved Lampit for the treatment of Chagas disease (American Trypanosomiasis), which is caused by trypanosoma cruzi (T. cruzi) in pediatric patients. Lampit was approved because it successfully treated patients who became immunoglobulin G (IgG) antibody negative or who showed an at least 20% decline in optical density on 2 different IgG antibody tests against antigens of T. cruzi.
Devices/equipment segment is expected to achieve tremendous growth in global pediatric healthcare market during the forecast period.
Application Outlook:
On the basis of application, the global pediatric healthcare market can be segmented into neonates (below 28 days), infants (29 days to less than 2 years), children (2 years to less than 12 years), adolescents (12 years to less than 21 years). Children (2 years to less than 12 years) segment accounted for the largest market share in the global pediatric healthcare market in 2020.
During the forecast period, the infants (29 days to less than 2 years) is estimated to witness fastest growth. Pediatric radiology for the given age group is experiencing substantial demand and is anticipated to contribute towards the segment’s growth over the future years. The tests are primarily carried out to check if there are no abnormalities in the infant since birth. Doctors prefer ultrasonography (USG) as the screening modality for infants because it is safe, and can be performed bedside. In some cases, doctors also carry out cross-sectional imaging for further evaluation. The market for tests and treatment for infants is also growing because special arrangements are being made for the safety of preterm infants (infants younger than 34 weeks) as these infants have immature lungs with surfactant shortage which can lead to alveolar insufficiency. As the breathing disorder progresses with time, disorders like cyanosis, dyspnea, grunting, and tachypnea can occur. Strategic initiatives are furthering the growth of global pediatric healthcare market. In September 2021, Beebe Healthcare and Nemours Children’s Health entered into a partnership to provide pediatric services to the infants, children and adolescents of Sussex County.
Distribution Channels Outlook:
The distribution channel segment in the global pediatric healthcare market has been classified into online distribution channels and offline distribution channels. The offline distribution channels category has been further segmented into pharmacy & drug stores, specialty stores, hospitals & clinics, and others. Offline distribution channels category was the largest market segment in 2020.Hospitals and retail clinics have encountered substantial demand and growth in the global pediatric healthcare market for prescription-based medications. In September 2021, Bylvay (odevixibat), the first drug approved in Europe for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC), became available to patients with prescription in Germany. This drug has been developed by Albireo Pharma Inc., a rare pediatric liver disease company engaged in developing various novel bile acid modulators, for the treatment of pruritus in all types of PFIC. Bylvay has also been approved in the USA. During the forecast period, online distribution channels category is expected to become fastest growing market segment.
Region Outlook:
North America accounted for a significant share in the global pediatric healthcare market in 2020. However, during the forecast period, Asia Pacific region is expected to become the fastest growing regional market due to rising count of children with disorders and diseases. Growing healthcare infrastructure in emerging economies including China, India, and Indonesia is also boosting the economic growth. Occurring throughout the world, protozoal infections are a major cause of morbidity and mortality in regions such as South-East Asia. Increasing development of medical infrastructure in Asian countries such as Japan, Singapore, & South Korea is speeding up the market growth. Governments of Asian countries like China and India are encouraging more research for drugs as well as technology that can ease medical treatments.
Competitive Landscape Outlook:
The report provides both, qualitative as well as quantitative research of global pediatric healthcare market. It also provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as affiliations, collaborations, mergers & acquisitions (M&A), and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the pediatric healthcare market are Allergan, Aveanna Healthcare LLC., BAYADA Home Health Care, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Cardinal Health, Eisai Co. Ltd., Epic Health Services, GE Healthcare (GENERAL ELECTRIC COMPANY), Gilead Sciences Inc., GlaxoSmithKline PLC, Koninklijke Philips N.V., Maksun Biotech Pvt. Ltd., Merck & Co. Inc., PAX HEALTHCARE, Pediapharm, Sanofi, Siemens Medical Solutions USA Inc., and Stryker amongst others.
Global Pediatric Healthcare Market:
By Offering
- Drugs
- General Anaesthetics and Oxygen
- Pain and Palliative Care
- Antiallergics
- Antidotes
- Anticonvulsants/ Antiepileptics
- Anti-Infective Medicines
- Anthelminthics
- Antibacterials
- Antifungal Medicines
- Antiviral Medicines
- Antiprotozoal Medicines
- Others
- Antimigraine Medicines
- Immunomodulators and Antineoplastics
- Medicines Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
- Cardiovascular Medicines
- Dermatological Medicines
- Disinfectants and Antiseptics
- Gastrointestinal Medicines
- Endocrine Disorders Medicines
- Immunologicals
- Others (Diagnostic Agents, Respiratory Tract Medicines, Etc.)
- Devices/Equipment
- In Vitro Diagnostic (IVD) Devices
- Diagnostic Imaging Devices
- Anesthesia and Respiratory Care Devices
- Cardiology Devices
- Orthopaedic Devices
- Telemedicine
- Monitoring Devices
- Blood Pressure
- Pulse Oximetry
- Temperature Monitoring
- Others
- Others
- Services
- Pediatric Surgical Services
- Nursing Services
- Pediatric Therapy
- Speech Therapy
- Physical Therapy
- Others
- Others
By Application
- Neonates (Below 28 days)
- Infants (29 days to less than 2 years)
- Children (2 years to less than 12 years)
- Adolescents (12 years to less than 21 years)
By Distribution Channels
- Online
- Offline
- Pharmacy & Drug Stores
- Specialty Stores
- Hospitals & Clinics
- Others
By Region
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
Table of Contents
Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2013 -
2017
1.2.2. Base Year: 2018
1.2.3. Forecast Years: 2021 –
2029
2.
Key Target Audiences
3.
Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage
Breakdown
3.1.3. Primary Interviews: Key
Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation
Methodology
3.5. Research Assumptions
4.
Recommendations and Insights
from RNR’s Perspective**
5.
Holistic Overview of Pediatric
Healthcare Market
6.
Market Synopsis: Pediatric Healthcare Market
7.
Pediatric Healthcare Market
Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Pediatric
Healthcare Market
7.4. Market Determinants Radar
Chart
7.5. Macro-Economic and
Micro-Economic Indicators: Pediatric Healthcare Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of Covid-19 on Pediatric
Healthcare Market
8.
Global Pediatric Healthcare
Market Analysis and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global Pediatric
Healthcare Market Revenue (US$ Mn)
8.2. Global Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Drugs (Definition,
Market Estimation and Penetration, 2015 – 2020, Market Forecast (2021 – 2029),
Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America,
Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on
General Anaesthetics and Oxygen , Pain and Palliative Care, Antiallergics,
Antidotes, Anticonvulsants/ Antiepileptics, Anti-Infective Medicines,
Antimigraine Medicines, Immunomodulators and Antineoplastics , Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.), Cardiovascular
Medicines, Dermatological Medicines, Disinfectants and Antiseptics,
Gastrointestinal Medicines, Endocrine Disorders Medicines, Immunologicals,
Others (Diagnostic Agents, Respiratory Tract Medicines, Etc.))
8.2.1.1. General Anaesthetics
and Oxygen
8.2.1.2. Pain and Palliative
Care
8.2.1.3. Antiallergics
8.2.1.4. Antidotes
8.2.1.5. Anticonvulsants/
Antiepileptics
8.2.1.6. Anti-Infective
Medicines
8.2.1.6.1.
Anthelminthics
8.2.1.6.2.
Antibacterials
8.2.1.6.3.
Antifungal Medicines
8.2.1.6.4.
Antiviral Medicines
8.2.1.6.5.
Antiprotozoal Medicines
8.2.1.6.6.
Others
8.2.1.7. Antimigraine Medicines
8.2.1.8. Immunomodulators and
Antineoplastics
8.2.1.9. Medicines Affecting
the Blood (Antianaemia Medicines, Coagulation, etc.)
8.2.1.10. Cardiovascular
Medicines
8.2.1.11. Dermatological
Medicines
8.2.1.12. Disinfectants and
Antiseptics
8.2.1.13. Gastrointestinal
Medicines
8.2.1.14. Endocrine Disorders
Medicines
8.2.1.15. Immunologicals
8.2.1.16. Others (Diagnostic
Agents, Respiratory Tract Medicines, Etc.)
8.2.2. Devices/Equipment
(Definition, Market Estimation and Penetration, 2015 – 2020, Market Forecast
(2021 – 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on In Vitro Diagnostic (IVD) Devices, Diagnostic Imaging Devices,
Anesthesia and Respiratory Care Devices, Cardiology Devices, Orthopaedic Devices, Telemedicine, Monitoring Devices, Others)
8.2.2.1. In Vitro Diagnostic
(IVD) Devices
8.2.2.2. Diagnostic Imaging
Devices
8.2.2.3. Anesthesia and
Respiratory Care Devices
8.2.2.4. Cardiology Devices
8.2.2.5. Orthopaedic Devices
8.2.2.6. Telemedicine
8.2.2.7. Monitoring Devices
8.2.2.7.1.
Blood Pressure
8.2.2.7.2.
Pulse Oximetry
8.2.2.7.3.
Temperature Monitoring
8.2.2.7.4.
Others
8.2.2.8. Others
8.2.3. Services (Definition,
Market Estimation and Penetration, 2015 – 2020, Market Forecast (2021 – 2029),
Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America,
Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on
Pediatric Surgical Services, Nursing Services, Pediatric Therapy, Others)
8.2.3.1. Pediatric Surgical
Services
8.2.3.2. Nursing Services
8.2.3.3. Pediatric Therapy
8.2.3.3.1.
Speech Therapy
8.2.3.3.2.
Physical Therapy
8.2.3.3.3.
Others
8.2.3.4. Others
8.3. Key Segment for
Channeling Investments
8.3.1. By Offering
9.
Global Pediatric Healthcare
Market Analysis and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Neonates (Below 28 days)
9.2.1.1. Definition
9.2.1.2. Market Estimation and
Penetration, 2015 – 2020
9.2.1.3. Market Forecast, 2021
– 2029
9.2.1.4. Compound Annual Growth
Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1.
North America
9.2.1.5.1.1. Market Estimation,
2015 – 2020
9.2.1.5.1.2. Market Forecast,
2021 – 2029
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation,
2015 – 2020
9.2.1.5.2.2. Market Forecast,
2021 – 2029
9.2.1.5.3.
Asia Pacific
9.2.1.5.3.1. Market Estimation,
2015 – 2020
9.2.1.5.3.2. Market Forecast,
2021 – 2029
9.2.1.5.4.
Middle East and Africa
9.2.1.5.4.1. Market Estimation,
2015 – 2020
9.2.1.5.4.2. Market Forecast,
2021 – 2029
9.2.1.5.5.
Latin America
9.2.1.5.5.1. Market Estimation,
2015 – 2020
9.2.1.5.5.2. Market Forecast,
2021 – 2029
9.2.2. Infants (29 days to less
than 2 years)
9.2.2.1. Definition
9.2.2.2. Market Estimation and
Penetration, 2015 – 2020
9.2.2.3. Market Forecast, 2021
– 2029
9.2.2.4. Compound Annual Growth
Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1.
North America
9.2.2.5.1.1. Market Estimation,
2015 – 2020
9.2.2.5.1.2. Market Forecast,
2021 – 2029
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation,
2015 – 2020
9.2.2.5.2.2. Market Forecast,
2021 – 2029
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1. Market Estimation,
2015 – 2020
9.2.2.5.3.2. Market Forecast,
2021 – 2029
9.2.2.5.4.
Middle East and Africa
9.2.2.5.4.1. Market Estimation,
2015 – 2020
9.2.2.5.4.2. Market Forecast,
2021 – 2029
9.2.2.5.5.
Latin America
9.2.2.5.5.1. Market Estimation,
2015 – 2020
9.2.2.5.5.2. Market Forecast,
2021 – 2029
9.2.3. Children (2 years to
less than 12 years)
9.2.3.1. Definition
9.2.3.2. Market Estimation and
Penetration, 2015 – 2020
9.2.3.3. Market Forecast, 2021
– 2029
9.2.3.4. Compound Annual Growth
Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1.
North America
9.2.3.5.1.1. Market Estimation,
2015 – 2020
9.2.3.5.1.2. Market Forecast,
2021 – 2029
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation,
2015 – 2020
9.2.3.5.2.2. Market Forecast,
2021 – 2029
9.2.3.5.3.
Asia Pacific
9.2.3.5.3.1. Market Estimation,
2015 – 2020
9.2.3.5.3.2. Market Forecast,
2021 – 2029
9.2.3.5.4.
Middle East and Africa
9.2.3.5.4.1. Market Estimation,
2015 – 2020
9.2.3.5.4.2. Market Forecast,
2021 – 2029
9.2.3.5.5.
Latin America
9.2.3.5.5.1. Market Estimation,
2015 – 2020
9.2.3.5.5.2. Market Forecast,
2021 – 2029
9.2.4. Adolescents (12 years to
less than 21 years)
9.2.4.1. Definition
9.2.4.2. Market Estimation and
Penetration, 2015 – 2020
9.2.4.3. Market Forecast, 2021
– 2029
9.2.4.4. Compound Annual Growth
Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1.
North America
9.2.4.5.1.1. Market Estimation,
2015 – 2020
9.2.4.5.1.2. Market Forecast,
2021 – 2029
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation,
2015 – 2020
9.2.4.5.2.2. Market Forecast,
2021 – 2029
9.2.4.5.3.
Asia Pacific
9.2.4.5.3.1. Market Estimation,
2015 – 2020
9.2.4.5.3.2. Market Forecast,
2021 – 2029
9.2.4.5.4.
Middle East and Africa
9.2.4.5.4.1. Market Estimation,
2015 – 2020
9.2.4.5.4.2. Market Forecast,
2021 – 2029
9.2.4.5.5.
Latin America
9.2.4.5.5.1. Market Estimation,
2015 – 2020
9.2.4.5.5.2. Market Forecast,
2021 – 2029
9.3. Key Segment for
Channeling Investments
9.3.1. By Application
10. Global Pediatric Healthcare Market Analysis and Forecasts,
2021 – 2029
10.1. Overview
10.2. Global Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
10.2.1. Online
10.2.1.1. Definition
10.2.1.2. Market Estimation and
Penetration, 2015 – 2020
10.2.1.3. Market Forecast, 2021
– 2029
10.2.1.4. Compound Annual Growth
Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 – 2020
10.2.1.5.1.2. Market Forecast,
2021 – 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2020
10.2.1.5.2.2. Market Forecast,
2021 – 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2020
10.2.1.5.3.2. Market Forecast,
2021 – 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2020
10.2.1.5.4.2. Market Forecast,
2021 – 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 – 2020
10.2.1.5.5.2. Market Forecast,
2021 – 2029
10.2.2. Offline (Definition,
Market Estimation and Penetration, 2015 – 2020, Market Estimation (2015 –
2019), Market Forecast (2021 – 2029), Compound Annual Growth Rate (CAGR),
Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and
Africa, Latin America) and Information on Pharmacy and Drug Stores, Specialty
Stores, Hospitals and Clinics, Others)
10.2.2.1. Pharmacy and Drug
Stores
10.2.2.2. Specialty Stores
10.2.2.3. Hospitals and Clinics
10.2.2.4. Others
10.3. Key Segment for
Channeling Investments
10.3.1. By Distribution Channel
11. North America Pediatric Healthcare Market Analysis and
Forecasts, 2019 - 2027
11.1. Overview
11.1.1. North America Pediatric
Healthcare Market Revenue (US$ Mn)
11.2. North America Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
11.2.1. Drugs
11.2.1.1. General Anaesthetics
and Oxygen
11.2.1.2. Pain and Palliative
Care
11.2.1.3. Antiallergics
11.2.1.4. Antidotes
11.2.1.5. Anticonvulsants/
Antiepileptics
11.2.1.6. Anti-Infective
Medicines
11.2.1.6.1. Anthelminthics
11.2.1.6.2. Antibacterials
11.2.1.6.3. Antifungal Medicines
11.2.1.6.4. Antiviral Medicines
11.2.1.6.5. Antiprotozoal Medicines
11.2.1.6.6. Others
11.2.1.7. Antimigraine
Medicines
11.2.1.8. Immunomodulators and
Antineoplastics
11.2.1.9. Medicines Affecting
the Blood (Antianaemia Medicines, Coagulation, etc.)
11.2.1.10. Cardiovascular
Medicines
11.2.1.11. Dermatological
Medicines
11.2.1.12. Disinfectants and
Antiseptics
11.2.1.13. Gastrointestinal
Medicines
11.2.1.14. Endocrine Disorders
Medicines
11.2.1.15. Immunologicals
11.2.1.16. Others (Diagnostic
Agents, Respiratory Tract Medicines, Etc.)
11.2.2. Devices/Equipment
11.2.2.1. In Vitro Diagnostic
(IVD) Devices
11.2.2.2. Diagnostic Imaging
Devices
11.2.2.3. Anesthesia and
Respiratory Care Devices
11.2.2.4. Cardiology Devices
11.2.2.5. Orthopaedic Devices
11.2.2.6. Telemedicine
11.2.2.7. Monitoring Devices
11.2.2.7.1. Blood Pressure
11.2.2.7.2. Pulse Oximetry
11.2.2.7.3. Temperature Monitoring
11.2.2.7.4. Others
11.2.2.8. Others
11.2.3. Services
11.2.3.1. Pediatric Surgical
Services
11.2.3.2. Nursing Services
11.2.3.3. Pediatric Therapy
11.2.3.3.1. Speech Therapy
11.2.3.3.2. Physical Therapy
11.2.3.3.3. Others
11.2.3.4. Others
11.3. North America Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1. Neonates (Below 28
days)
11.3.2. Infants (29 days to
less than 2 years)
11.3.3. Children (2 years to
less than 12 years)
11.3.4. Adolescents (12 years
to less than 21 years)
11.4. North America Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.1. Online
11.4.2. Offline
11.4.2.1. Pharmacy and Drug
Stores
11.4.2.2. Specialty Stores
11.4.2.3. Hospitals and Clinics
11.4.2.4. Others
11.5. North America Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.1.1.1. Drugs
11.5.1.1.1.1. General
Anaesthetics and Oxygen
11.5.1.1.1.2. Pain and
Palliative Care
11.5.1.1.1.3. Antiallergics
11.5.1.1.1.4. Antidotes
11.5.1.1.1.5. Anticonvulsants/
Antiepileptics
11.5.1.1.1.6. Anti-Infective
Medicines
11.5.1.1.1.6.1. Anthelminthics
11.5.1.1.1.6.2. Antibacterials
11.5.1.1.1.6.3. Antifungal
Medicines
11.5.1.1.1.6.4. Antiviral
Medicines
11.5.1.1.1.6.5. Antiprotozoal
Medicines
11.5.1.1.1.6.6. Others
11.5.1.1.1.7. Antimigraine
Medicines
11.5.1.1.1.8. Immunomodulators
and Antineoplastics
11.5.1.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
11.5.1.1.1.10. Cardiovascular
Medicines
11.5.1.1.1.11. Dermatological
Medicines
11.5.1.1.1.12. Disinfectants
and Antiseptics
11.5.1.1.1.13. Gastrointestinal
Medicines
11.5.1.1.1.14. Endocrine
Disorders Medicines
11.5.1.1.1.15. Immunologicals
11.5.1.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
11.5.1.1.2. Devices/Equipment
11.5.1.1.2.1. In Vitro
Diagnostic (IVD) Devices
11.5.1.1.2.2. Diagnostic
Imaging Devices
11.5.1.1.2.3. Anesthesia and
Respiratory Care Devices
11.5.1.1.2.4. Cardiology
Devices
11.5.1.1.2.5. Orthopaedic Devices
11.5.1.1.2.6. Telemedicine
11.5.1.1.2.7. Monitoring Devices
11.5.1.1.2.7.1. Blood Pressure
11.5.1.1.2.7.2. Pulse Oximetry
11.5.1.1.2.7.3. Temperature
Monitoring
11.5.1.1.2.7.4. Others
11.5.1.1.2.8. Others
11.5.1.1.3. Services
11.5.1.1.3.1. Pediatric
Surgical Services
11.5.1.1.3.2. Nursing Services
11.5.1.1.3.3. Pediatric Therapy
11.5.1.1.3.3.1. Speech Therapy
11.5.1.1.3.3.2. Physical
Therapy
11.5.1.1.3.3.3. Others
11.5.1.1.3.4. Others
11.5.1.2. U.S Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1. Neonates (Below 28 days)
11.5.1.2.2. Infants (29 days to less than 2 years)
11.5.1.2.3. Children (2 years to less than 12 years)
11.5.1.2.4. Adolescents (12 years to less than 21 years)
11.5.1.3. U.S Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.5.1.3.1. Online
11.5.1.3.2. Offline
11.5.1.3.2.1. Pharmacy and Drug
Stores
11.5.1.3.2.2. Specialty Stores
11.5.1.3.2.3. Hospitals and
Clinics
11.5.1.3.2.4. Others
11.5.2. Canada
11.5.2.1. Canada Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.2.1.1. Drugs
11.5.2.1.1.1. General
Anaesthetics and Oxygen
11.5.2.1.1.2. Pain and
Palliative Care
11.5.2.1.1.3. Antiallergics
11.5.2.1.1.4. Antidotes
11.5.2.1.1.5. Anticonvulsants/
Antiepileptics
11.5.2.1.1.6. Anti-Infective
Medicines
11.5.2.1.1.6.1. Anthelminthics
11.5.2.1.1.6.2. Antibacterials
11.5.2.1.1.6.3. Antifungal
Medicines
11.5.2.1.1.6.4. Antiviral
Medicines
11.5.2.1.1.6.5. Antiprotozoal
Medicines
11.5.2.1.1.6.6. Others
11.5.2.1.1.7. Antimigraine
Medicines
11.5.2.1.1.8. Immunomodulators
and Antineoplastics
11.5.2.1.1.9. Medicines Affecting
the Blood (Antianaemia Medicines, Coagulation, etc.)
11.5.2.1.1.10. Cardiovascular
Medicines
11.5.2.1.1.11. Dermatological
Medicines
11.5.2.1.1.12. Disinfectants
and Antiseptics
11.5.2.1.1.13. Gastrointestinal
Medicines
11.5.2.1.1.14. Endocrine
Disorders Medicines
11.5.2.1.1.15. Immunologicals
11.5.2.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
11.5.2.1.2. Devices/Equipment
11.5.2.1.2.1. In Vitro
Diagnostic (IVD) Devices
11.5.2.1.2.2. Diagnostic
Imaging Devices
11.5.2.1.2.3. Anesthesia and
Respiratory Care Devices
11.5.2.1.2.4. Cardiology
Devices
11.5.2.1.2.5. Orthopaedic Devices
11.5.2.1.2.6. Telemedicine
11.5.2.1.2.7. Monitoring
Devices
11.5.2.1.2.7.1. Blood Pressure
11.5.2.1.2.7.2. Pulse Oximetry
11.5.2.1.2.7.3. Temperature
Monitoring
11.5.2.1.2.7.4. Others
11.5.2.1.2.8. Others
11.5.2.1.3. Services
11.5.2.1.3.1. Pediatric
Surgical Services
11.5.2.1.3.2. Nursing Services
11.5.2.1.3.3. Pediatric Therapy
11.5.2.1.3.3.1. Speech Therapy
11.5.2.1.3.3.2. Physical
Therapy
11.5.2.1.3.3.3. Others
11.5.2.1.3.4. Others
11.5.2.2. Canada Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1. Neonates (Below 28 days)
11.5.2.2.2. Infants (29 days to less than 2 years)
11.5.2.2.3. Children (2 years to less than 12 years)
11.5.2.2.4. Adolescents (12 years to less than 21 years)
11.5.2.3. Canada Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.5.2.3.1. Online
11.5.2.3.2. Offline
11.5.2.3.2.1. Pharmacy and Drug
Stores
11.5.2.3.2.2. Specialty Stores
11.5.2.3.2.3. Hospitals and
Clinics
11.5.2.3.2.4. Others
11.5.3. Mexico
11.5.3.1. Mexico Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.3.1.1. Drugs
11.5.3.1.1.1. General
Anaesthetics and Oxygen
11.5.3.1.1.2. Pain and
Palliative Care
11.5.3.1.1.3. Antiallergics
11.5.3.1.1.4. Antidotes
11.5.3.1.1.5. Anticonvulsants/
Antiepileptics
11.5.3.1.1.6. Anti-Infective
Medicines
11.5.3.1.1.6.1. Anthelminthics
11.5.3.1.1.6.2. Antibacterials
11.5.3.1.1.6.3. Antifungal
Medicines
11.5.3.1.1.6.4. Antiviral
Medicines
11.5.3.1.1.6.5. Antiprotozoal
Medicines
11.5.3.1.1.6.6. Others
11.5.3.1.1.7. Antimigraine
Medicines
11.5.3.1.1.8. Immunomodulators
and Antineoplastics
11.5.3.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
11.5.3.1.1.10. Cardiovascular
Medicines
11.5.3.1.1.11. Dermatological
Medicines
11.5.3.1.1.12. Disinfectants
and Antiseptics
11.5.3.1.1.13. Gastrointestinal
Medicines
11.5.3.1.1.14. Endocrine
Disorders Medicines
11.5.3.1.1.15. Immunologicals
11.5.3.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
11.5.3.1.2. Devices/Equipment
11.5.3.1.2.1. In Vitro
Diagnostic (IVD) Devices
11.5.3.1.2.2. Diagnostic
Imaging Devices
11.5.3.1.2.3. Anesthesia and
Respiratory Care Devices
11.5.3.1.2.4. Cardiology
Devices
11.5.3.1.2.5. Orthopaedic Devices
11.5.3.1.2.6. Telemedicine
11.5.3.1.2.7. Monitoring
Devices
11.5.3.1.2.7.1. Blood Pressure
11.5.3.1.2.7.2. Pulse Oximetry
11.5.3.1.2.7.3. Temperature
Monitoring
11.5.3.1.2.7.4. Others
11.5.3.1.2.8. Others
11.5.3.1.3. Services
11.5.3.1.3.1. Pediatric
Surgical Services
11.5.3.1.3.2. Nursing Services
11.5.3.1.3.3. Pediatric Therapy
11.5.3.1.3.3.1. Speech Therapy
11.5.3.1.3.3.2. Physical
Therapy
11.5.3.1.3.3.3. Others
11.5.3.1.3.4. Others
11.5.3.2. Mexico Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1. Neonates (Below 28 days)
11.5.3.2.2. Infants (29 days to less than 2 years)
11.5.3.2.3. Children (2 years to less than 12 years)
11.5.3.2.4. Adolescents (12 years to less than 21 years)
11.5.3.3. Mexico Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.5.3.3.1. Online
11.5.3.3.2. Offline
11.5.3.3.2.1. Pharmacy and Drug
Stores
11.5.3.3.2.2. Specialty Stores
11.5.3.3.2.3. Hospitals and
Clinics
11.5.3.3.2.4. Others
11.5.4. Rest of North America
11.5.4.1. Rest of North America
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.4.1.1. Drugs
11.5.4.1.1.1. General
Anaesthetics and Oxygen
11.5.4.1.1.2. Pain and
Palliative Care
11.5.4.1.1.3. Antiallergics
11.5.4.1.1.4. Antidotes
11.5.4.1.1.5. Anticonvulsants/
Antiepileptics
11.5.4.1.1.6. Anti-Infective
Medicines
11.5.4.1.1.6.1. Anthelminthics
11.5.4.1.1.6.2. Antibacterials
11.5.4.1.1.6.3. Antifungal
Medicines
11.5.4.1.1.6.4. Antiviral
Medicines
11.5.4.1.1.6.5. Antiprotozoal
Medicines
11.5.4.1.1.6.6. Others
11.5.4.1.1.7. Antimigraine
Medicines
11.5.4.1.1.8. Immunomodulators
and Antineoplastics
11.5.4.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
11.5.4.1.1.10. Cardiovascular
Medicines
11.5.4.1.1.11. Dermatological
Medicines
11.5.4.1.1.12. Disinfectants
and Antiseptics
11.5.4.1.1.13. Gastrointestinal
Medicines
11.5.4.1.1.14. Endocrine
Disorders Medicines
11.5.4.1.1.15. Immunologicals
11.5.4.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
11.5.4.1.2. Devices/Equipment
11.5.4.1.2.1. In Vitro
Diagnostic (IVD) Devices
11.5.4.1.2.2. Diagnostic
Imaging Devices
11.5.4.1.2.3. Anesthesia and
Respiratory Care Devices
11.5.4.1.2.4. Cardiology
Devices
11.5.4.1.2.5. Orthopaedic Devices
11.5.4.1.2.6. Telemedicine
11.5.4.1.2.7. Monitoring
Devices
11.5.4.1.2.7.1. Blood Pressure
11.5.4.1.2.7.2. Pulse Oximetry
11.5.4.1.2.7.3. Temperature
Monitoring
11.5.4.1.2.7.4. Others
11.5.4.1.2.8. Others
11.5.4.1.3. Services
11.5.4.1.3.1. Pediatric
Surgical Services
11.5.4.1.3.2. Nursing Services
11.5.4.1.3.3. Pediatric Therapy
11.5.4.1.3.3.1. Speech Therapy
11.5.4.1.3.3.2. Physical
Therapy
11.5.4.1.3.3.3. Others
11.5.4.1.3.4. Others
11.5.4.2. Rest of North America
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
11.5.4.2.1. Neonates (Below 28 days)
11.5.4.2.2. Infants (29 days to less than 2 years)
11.5.4.2.3. Children (2 years to less than 12 years)
11.5.4.2.4. Adolescents (12 years to less than 21 years)
11.5.4.3. Rest of North America
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
11.5.4.3.1. Online
11.5.4.3.2. Offline
11.5.4.3.2.1. Pharmacy and Drug
Stores
11.5.4.3.2.2. Specialty Stores
11.5.4.3.2.3. Hospitals and
Clinics
11.5.4.3.2.4. Others
11.6. Key Segment for
Channeling Investments
11.6.1. By Country
11.6.2. By Offering
11.6.3. By Application
11.6.4. By Distribution Channel
12. Europe Pediatric Healthcare Market Analysis and Forecasts,
2019 - 2027
12.1. Overview
12.1.1. Europe Pediatric Healthcare
Market Revenue (US$ Mn)
12.2. Europe Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
12.2.1. Drugs
12.2.1.1. General Anaesthetics
and Oxygen
12.2.1.2. Pain and Palliative
Care
12.2.1.3. Antiallergics
12.2.1.4. Antidotes
12.2.1.5. Anticonvulsants/
Antiepileptics
12.2.1.6. Anti-Infective
Medicines
12.2.1.6.1. Anthelminthics
12.2.1.6.2. Antibacterials
12.2.1.6.3. Antifungal Medicines
12.2.1.6.4. Antiviral Medicines
12.2.1.6.5. Antiprotozoal Medicines
12.2.1.6.6. Others
12.2.1.7. Antimigraine
Medicines
12.2.1.8. Immunomodulators and
Antineoplastics
12.2.1.9. Medicines Affecting
the Blood (Antianaemia Medicines, Coagulation, etc.)
12.2.1.10. Cardiovascular
Medicines
12.2.1.11. Dermatological
Medicines
12.2.1.12. Disinfectants and
Antiseptics
12.2.1.13. Gastrointestinal
Medicines
12.2.1.14. Endocrine Disorders
Medicines
12.2.1.15. Immunologicals
12.2.1.16. Others (Diagnostic
Agents, Respiratory Tract Medicines, Etc.)
12.2.2. Devices/Equipment
12.2.2.1. In Vitro Diagnostic
(IVD) Devices
12.2.2.2. Diagnostic Imaging
Devices
12.2.2.3. Anesthesia and
Respiratory Care Devices
12.2.2.4. Cardiology Devices
12.2.2.5. Orthopaedic Devices
12.2.2.6. Telemedicine
12.2.2.7. Monitoring Devices
12.2.2.7.1. Blood Pressure
12.2.2.7.2. Pulse Oximetry
12.2.2.7.3. Temperature Monitoring
12.2.2.7.4. Others
12.2.2.8. Others
12.2.3. Services
12.2.3.1. Pediatric Surgical
Services
12.2.3.2. Nursing Services
12.2.3.3. Pediatric Therapy
12.2.3.3.1. Speech Therapy
12.2.3.3.2. Physical Therapy
12.2.3.3.3. Others
12.2.3.4. Others
12.3. Europe Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1. Neonates (Below 28
days)
12.3.2. Infants (29 days to
less than 2 years)
12.3.3. Children (2 years to
less than 12 years)
12.3.4. Adolescents (12 years
to less than 21 years)
12.4. Europe Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.1. Online
12.4.2. Offline
12.4.2.1. Pharmacy and Drug
Stores
12.4.2.2. Specialty Stores
12.4.2.3. Hospitals and Clinics
12.4.2.4. Others
12.5. Europe Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.1.1.1. Drugs
12.5.1.1.1.1. General
Anaesthetics and Oxygen
12.5.1.1.1.2. Pain and
Palliative Care
12.5.1.1.1.3. Antiallergics
12.5.1.1.1.4. Antidotes
12.5.1.1.1.5. Anticonvulsants/
Antiepileptics
12.5.1.1.1.6. Anti-Infective
Medicines
12.5.1.1.1.6.1. Anthelminthics
12.5.1.1.1.6.2. Antibacterials
12.5.1.1.1.6.3. Antifungal
Medicines
12.5.1.1.1.6.4. Antiviral
Medicines
12.5.1.1.1.6.5. Antiprotozoal
Medicines
12.5.1.1.1.6.6. Others
12.5.1.1.1.7. Antimigraine
Medicines
12.5.1.1.1.8. Immunomodulators
and Antineoplastics
12.5.1.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
12.5.1.1.1.10. Cardiovascular
Medicines
12.5.1.1.1.11. Dermatological
Medicines
12.5.1.1.1.12. Disinfectants
and Antiseptics
12.5.1.1.1.13. Gastrointestinal
Medicines
12.5.1.1.1.14. Endocrine
Disorders Medicines
12.5.1.1.1.15. Immunologicals
12.5.1.1.1.16. Others (Diagnostic
Agents, Respiratory Tract Medicines, Etc.)
12.5.1.1.2. Devices/Equipment
12.5.1.1.2.1. In Vitro
Diagnostic (IVD) Devices
12.5.1.1.2.2. Diagnostic
Imaging Devices
12.5.1.1.2.3. Anesthesia and
Respiratory Care Devices
12.5.1.1.2.4. Cardiology
Devices
12.5.1.1.2.5. Orthopaedic Devices
12.5.1.1.2.6. Telemedicine
12.5.1.1.2.7. Monitoring
Devices
12.5.1.1.2.7.1. Blood Pressure
12.5.1.1.2.7.2. Pulse Oximetry
12.5.1.1.2.7.3. Temperature
Monitoring
12.5.1.1.2.7.4. Others
12.5.1.1.2.8. Others
12.5.1.1.3. Services
12.5.1.1.3.1. Pediatric
Surgical Services
12.5.1.1.3.2. Nursing Services
12.5.1.1.3.3. Pediatric Therapy
12.5.1.1.3.3.1. Speech Therapy
12.5.1.1.3.3.2. Physical
Therapy
12.5.1.1.3.3.3. Others
12.5.1.1.3.4. Others
12.5.1.2. France Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1. Neonates (Below 28 days)
12.5.1.2.2. Infants (29 days to less than 2 years)
12.5.1.2.3. Children (2 years to less than 12 years)
12.5.1.2.4. Adolescents (12 years to less than 21 years)
12.5.1.3. France Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.1.3.1. Online
12.5.1.3.2. Offline
12.5.1.3.2.1. Pharmacy and Drug
Stores
12.5.1.3.2.2. Specialty Stores
12.5.1.3.2.3. Hospitals and
Clinics
12.5.1.3.2.4. Others
12.5.2. The UK
12.5.2.1. The UK Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.2.1.1. Drugs
12.5.2.1.1.1. General
Anaesthetics and Oxygen
12.5.2.1.1.2. Pain and
Palliative Care
12.5.2.1.1.3. Antiallergics
12.5.2.1.1.4. Antidotes
12.5.2.1.1.5. Anticonvulsants/
Antiepileptics
12.5.2.1.1.6. Anti-Infective
Medicines
12.5.2.1.1.6.1. Anthelminthics
12.5.2.1.1.6.2. Antibacterials
12.5.2.1.1.6.3. Antifungal
Medicines
12.5.2.1.1.6.4. Antiviral
Medicines
12.5.2.1.1.6.5. Antiprotozoal
Medicines
12.5.2.1.1.6.6. Others
12.5.2.1.1.7. Antimigraine
Medicines
12.5.2.1.1.8. Immunomodulators
and Antineoplastics
12.5.2.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
12.5.2.1.1.10. Cardiovascular
Medicines
12.5.2.1.1.11. Dermatological
Medicines
12.5.2.1.1.12. Disinfectants
and Antiseptics
12.5.2.1.1.13. Gastrointestinal
Medicines
12.5.2.1.1.14. Endocrine
Disorders Medicines
12.5.2.1.1.15. Immunologicals
12.5.2.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
12.5.2.1.2. Devices/Equipment
12.5.2.1.2.1. In Vitro
Diagnostic (IVD) Devices
12.5.2.1.2.2. Diagnostic
Imaging Devices
12.5.2.1.2.3. Anesthesia and
Respiratory Care Devices
12.5.2.1.2.4. Cardiology
Devices
12.5.2.1.2.5. Orthopaedic Devices
12.5.2.1.2.6. Telemedicine
12.5.2.1.2.7. Monitoring
Devices
12.5.2.1.2.7.1. Blood Pressure
12.5.2.1.2.7.2. Pulse Oximetry
12.5.2.1.2.7.3. Temperature
Monitoring
12.5.2.1.2.7.4. Others
12.5.2.1.2.8. Others
12.5.2.1.3. Services
12.5.2.1.3.1. Pediatric
Surgical Services
12.5.2.1.3.2. Nursing Services
12.5.2.1.3.3. Pediatric Therapy
12.5.2.1.3.3.1. Speech Therapy
12.5.2.1.3.3.2. Physical
Therapy
12.5.2.1.3.3.3. Others
12.5.2.1.3.4. Others
12.5.2.2. The UK Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1. Neonates (Below 28 days)
12.5.2.2.2. Infants (29 days to less than 2 years)
12.5.2.2.3. Children (2 years to less than 12 years)
12.5.2.2.4. Adolescents (12 years to less than 21 years)
12.5.2.3. The UK Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.2.3.1. Online
12.5.2.3.2. Offline
12.5.2.3.2.1. Pharmacy and Drug
Stores
12.5.2.3.2.2. Specialty Stores
12.5.2.3.2.3. Hospitals and
Clinics
12.5.2.3.2.4. Others
12.5.3. Spain
12.5.3.1. Spain Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.3.1.1. Drugs
12.5.3.1.1.1. General
Anaesthetics and Oxygen
12.5.3.1.1.2. Pain and
Palliative Care
12.5.3.1.1.3. Antiallergics
12.5.3.1.1.4. Antidotes
12.5.3.1.1.5. Anticonvulsants/
Antiepileptics
12.5.3.1.1.6. Anti-Infective
Medicines
12.5.3.1.1.6.1. Anthelminthics
12.5.3.1.1.6.2. Antibacterials
12.5.3.1.1.6.3. Antifungal
Medicines
12.5.3.1.1.6.4. Antiviral
Medicines
12.5.3.1.1.6.5. Antiprotozoal
Medicines
12.5.3.1.1.6.6. Others
12.5.3.1.1.7. Antimigraine
Medicines
12.5.3.1.1.8. Immunomodulators
and Antineoplastics
12.5.3.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
12.5.3.1.1.10. Cardiovascular
Medicines
12.5.3.1.1.11. Dermatological
Medicines
12.5.3.1.1.12. Disinfectants
and Antiseptics
12.5.3.1.1.13. Gastrointestinal
Medicines
12.5.3.1.1.14. Endocrine
Disorders Medicines
12.5.3.1.1.15. Immunologicals
12.5.3.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
12.5.3.1.2. Devices/Equipment
12.5.3.1.2.1. In Vitro
Diagnostic (IVD) Devices
12.5.3.1.2.2. Diagnostic
Imaging Devices
12.5.3.1.2.3. Anesthesia and
Respiratory Care Devices
12.5.3.1.2.4. Cardiology
Devices
12.5.3.1.2.5. Orthopaedic Devices
12.5.3.1.2.6. Telemedicine
12.5.3.1.2.7. Monitoring
Devices
12.5.3.1.2.7.1. Blood Pressure
12.5.3.1.2.7.2. Pulse Oximetry
12.5.3.1.2.7.3. Temperature
Monitoring
12.5.3.1.2.7.4. Others
12.5.3.1.2.8. Others
12.5.3.1.3. Services
12.5.3.1.3.1. Pediatric
Surgical Services
12.5.3.1.3.2. Nursing Services
12.5.3.1.3.3. Pediatric Therapy
12.5.3.1.3.3.1. Speech Therapy
12.5.3.1.3.3.2. Physical
Therapy
12.5.3.1.3.3.3. Others
12.5.3.1.3.4. Others
12.5.3.2. Spain Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1. Neonates (Below 28 days)
12.5.3.2.2. Infants (29 days to less than 2 years)
12.5.3.2.3. Children (2 years to less than 12 years)
12.5.3.2.4. Adolescents (12 years to less than 21 years)
12.5.3.3. Spain Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.3.3.1. Online
12.5.3.3.2. Offline
12.5.3.3.2.1. Pharmacy and Drug
Stores
12.5.3.3.2.2. Specialty Stores
12.5.3.3.2.3. Hospitals and Clinics
12.5.3.3.2.4. Others
12.5.4. Germany
12.5.4.1. Germany Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.4.1.1. Drugs
12.5.4.1.1.1. General
Anaesthetics and Oxygen
12.5.4.1.1.2. Pain and
Palliative Care
12.5.4.1.1.3. Antiallergics
12.5.4.1.1.4. Antidotes
12.5.4.1.1.5. Anticonvulsants/
Antiepileptics
12.5.4.1.1.6. Anti-Infective
Medicines
12.5.4.1.1.6.1. Anthelminthics
12.5.4.1.1.6.2. Antibacterials
12.5.4.1.1.6.3. Antifungal
Medicines
12.5.4.1.1.6.4. Antiviral
Medicines
12.5.4.1.1.6.5. Antiprotozoal
Medicines
12.5.4.1.1.6.6. Others
12.5.4.1.1.7. Antimigraine
Medicines
12.5.4.1.1.8. Immunomodulators
and Antineoplastics
12.5.4.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
12.5.4.1.1.10. Cardiovascular
Medicines
12.5.4.1.1.11. Dermatological
Medicines
12.5.4.1.1.12. Disinfectants
and Antiseptics
12.5.4.1.1.13. Gastrointestinal
Medicines
12.5.4.1.1.14. Endocrine
Disorders Medicines
12.5.4.1.1.15. Immunologicals
12.5.4.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
12.5.4.1.2. Devices/Equipment
12.5.4.1.2.1. In Vitro
Diagnostic (IVD) Devices
12.5.4.1.2.2. Diagnostic
Imaging Devices
12.5.4.1.2.3. Anesthesia and
Respiratory Care Devices
12.5.4.1.2.4. Cardiology
Devices
12.5.4.1.2.5. Orthopaedic Devices
12.5.4.1.2.6. Telemedicine
12.5.4.1.2.7. Monitoring
Devices
12.5.4.1.2.7.1. Blood Pressure
12.5.4.1.2.7.2. Pulse Oximetry
12.5.4.1.2.7.3. Temperature
Monitoring
12.5.4.1.2.7.4. Others
12.5.4.1.2.8. Others
12.5.4.1.3. Services
12.5.4.1.3.1. Pediatric
Surgical Services
12.5.4.1.3.2. Nursing Services
12.5.4.1.3.3. Pediatric Therapy
12.5.4.1.3.3.1. Speech Therapy
12.5.4.1.3.3.2. Physical
Therapy
12.5.4.1.3.3.3. Others
12.5.4.1.3.4. Others
12.5.4.2. Germany Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1. Neonates (Below 28 days)
12.5.4.2.2. Infants (29 days to less than 2 years)
12.5.4.2.3. Children (2 years to less than 12 years)
12.5.4.2.4. Adolescents (12 years to less than 21 years)
12.5.4.3. Germany Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.4.3.1. Online
12.5.4.3.2. Offline
12.5.4.3.2.1. Pharmacy and Drug
Stores
12.5.4.3.2.2. Specialty Stores
12.5.4.3.2.3. Hospitals and
Clinics
12.5.4.3.2.4. Others
12.5.5. Italy
12.5.5.1. Italy Pediatric Healthcare
Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.5.1.1. Drugs
12.5.5.1.1.1. General
Anaesthetics and Oxygen
12.5.5.1.1.2. Pain and
Palliative Care
12.5.5.1.1.3. Antiallergics
12.5.5.1.1.4. Antidotes
12.5.5.1.1.5. Anticonvulsants/
Antiepileptics
12.5.5.1.1.6. Anti-Infective
Medicines
12.5.5.1.1.6.1. Anthelminthics
12.5.5.1.1.6.2. Antibacterials
12.5.5.1.1.6.3. Antifungal
Medicines
12.5.5.1.1.6.4. Antiviral
Medicines
12.5.5.1.1.6.5. Antiprotozoal
Medicines
12.5.5.1.1.6.6. Others
12.5.5.1.1.7. Antimigraine
Medicines
12.5.5.1.1.8. Immunomodulators
and Antineoplastics
12.5.5.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
12.5.5.1.1.10. Cardiovascular
Medicines
12.5.5.1.1.11. Dermatological
Medicines
12.5.5.1.1.12. Disinfectants
and Antiseptics
12.5.5.1.1.13. Gastrointestinal
Medicines
12.5.5.1.1.14. Endocrine
Disorders Medicines
12.5.5.1.1.15. Immunologicals
12.5.5.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
12.5.5.1.2. Devices/Equipment
12.5.5.1.2.1. In Vitro
Diagnostic (IVD) Devices
12.5.5.1.2.2. Diagnostic
Imaging Devices
12.5.5.1.2.3. Anesthesia and
Respiratory Care Devices
12.5.5.1.2.4. Cardiology
Devices
12.5.5.1.2.5. Orthopaedic Devices
12.5.5.1.2.6. Telemedicine
12.5.5.1.2.7. Monitoring
Devices
12.5.5.1.2.7.1. Blood Pressure
12.5.5.1.2.7.2. Pulse Oximetry
12.5.5.1.2.7.3. Temperature
Monitoring
12.5.5.1.2.7.4. Others
12.5.5.1.2.8. Others
12.5.5.1.3. Services
12.5.5.1.3.1. Pediatric
Surgical Services
12.5.5.1.3.2. Nursing Services
12.5.5.1.3.3. Pediatric Therapy
12.5.5.1.3.3.1. Speech Therapy
12.5.5.1.3.3.2. Physical
Therapy
12.5.5.1.3.3.3. Others
12.5.5.1.3.4. Others
12.5.5.2. Italy Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1. Neonates (Below 28 days)
12.5.5.2.2. Infants (29 days to less than 2 years)
12.5.5.2.3. Children (2 years to less than 12 years)
12.5.5.2.4. Adolescents (12 years to less than 21 years)
12.5.5.3. Italy Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.5.3.1. Online
12.5.5.3.2. Offline
12.5.5.3.2.1. Pharmacy and Drug
Stores
12.5.5.3.2.2. Specialty Stores
12.5.5.3.2.3. Hospitals and
Clinics
12.5.5.3.2.4. Others
12.5.6. Nordic Countries
12.5.6.1. Nordic Countries
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.6.1.1. Drugs
12.5.6.1.1.1. General
Anaesthetics and Oxygen
12.5.6.1.1.2. Pain and
Palliative Care
12.5.6.1.1.3. Antiallergics
12.5.6.1.1.4. Antidotes
12.5.6.1.1.5. Anticonvulsants/
Antiepileptics
12.5.6.1.1.6. Anti-Infective
Medicines
12.5.6.1.1.6.1. Anthelminthics
12.5.6.1.1.6.2. Antibacterials
12.5.6.1.1.6.3. Antifungal
Medicines
12.5.6.1.1.6.4. Antiviral Medicines
12.5.6.1.1.6.5. Antiprotozoal
Medicines
12.5.6.1.1.6.6. Others
12.5.6.1.1.7. Antimigraine
Medicines
12.5.6.1.1.8. Immunomodulators
and Antineoplastics
12.5.6.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
12.5.6.1.1.10. Cardiovascular
Medicines
12.5.6.1.1.11. Dermatological
Medicines
12.5.6.1.1.12. Disinfectants
and Antiseptics
12.5.6.1.1.13. Gastrointestinal
Medicines
12.5.6.1.1.14. Endocrine
Disorders Medicines
12.5.6.1.1.15. Immunologicals
12.5.6.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
12.5.6.1.2. Devices/Equipment
12.5.6.1.2.1. In Vitro
Diagnostic (IVD) Devices
12.5.6.1.2.2. Diagnostic
Imaging Devices
12.5.6.1.2.3. Anesthesia and
Respiratory Care Devices
12.5.6.1.2.4. Cardiology
Devices
12.5.6.1.2.5. Orthopaedic Devices
12.5.6.1.2.6. Telemedicine
12.5.6.1.2.7. Monitoring
Devices
12.5.6.1.2.7.1. Blood Pressure
12.5.6.1.2.7.2. Pulse Oximetry
12.5.6.1.2.7.3. Temperature
Monitoring
12.5.6.1.2.7.4. Others
12.5.6.1.2.8. Others
12.5.6.1.3. Services
12.5.6.1.3.1. Pediatric
Surgical Services
12.5.6.1.3.2. Nursing Services
12.5.6.1.3.3. Pediatric Therapy
12.5.6.1.3.3.1. Speech Therapy
12.5.6.1.3.3.2. Physical
Therapy
12.5.6.1.3.3.3. Others
12.5.6.1.3.4. Others
12.5.6.2. Nordic Countries
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.5.6.2.1. Neonates (Below 28 days)
12.5.6.2.2. Infants (29 days to less than 2 years)
12.5.6.2.3. Children (2 years to less than 12 years)
12.5.6.2.4. Adolescents (12 years to less than 21 years)
12.5.6.3. Nordic Countries
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.5.6.3.1. Online
12.5.6.3.2. Offline
12.5.6.3.2.1. Pharmacy and Drug
Stores
12.5.6.3.2.2. Specialty Stores
12.5.6.3.2.3. Hospitals and
Clinics
12.5.6.3.2.4. Others
12.5.6.4. Nordic Countries
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux Union
12.5.7.1. Benelux Union
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.7.1.1. Drugs
12.5.7.1.1.1. General
Anaesthetics and Oxygen
12.5.7.1.1.2. Pain and
Palliative Care
12.5.7.1.1.3. Antiallergics
12.5.7.1.1.4. Antidotes
12.5.7.1.1.5. Anticonvulsants/
Antiepileptics
12.5.7.1.1.6. Anti-Infective
Medicines
12.5.7.1.1.6.1. Anthelminthics
12.5.7.1.1.6.2. Antibacterials
12.5.7.1.1.6.3. Antifungal
Medicines
12.5.7.1.1.6.4. Antiviral
Medicines
12.5.7.1.1.6.5. Antiprotozoal
Medicines
12.5.7.1.1.6.6. Others
12.5.7.1.1.7. Antimigraine
Medicines
12.5.7.1.1.8. Immunomodulators
and Antineoplastics
12.5.7.1.1.9. Medicines Affecting
the Blood (Antianaemia Medicines, Coagulation, etc.)
12.5.7.1.1.10. Cardiovascular
Medicines
12.5.7.1.1.11. Dermatological
Medicines
12.5.7.1.1.12. Disinfectants
and Antiseptics
12.5.7.1.1.13. Gastrointestinal
Medicines
12.5.7.1.1.14. Endocrine
Disorders Medicines
12.5.7.1.1.15. Immunologicals
12.5.7.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
12.5.7.1.2. Devices/Equipment
12.5.7.1.2.1. In Vitro
Diagnostic (IVD) Devices
12.5.7.1.2.2. Diagnostic
Imaging Devices
12.5.7.1.2.3. Anesthesia and
Respiratory Care Devices
12.5.7.1.2.4. Cardiology
Devices
12.5.7.1.2.5. Orthopaedic Devices
12.5.7.1.2.6. Telemedicine
12.5.7.1.2.7. Monitoring
Devices
12.5.7.1.2.7.1. Blood Pressure
12.5.7.1.2.7.2. Pulse Oximetry
12.5.7.1.2.7.3. Temperature
Monitoring
12.5.7.1.2.7.4. Others
12.5.7.1.2.8. Others
12.5.7.1.3. Services
12.5.7.1.3.1. Pediatric
Surgical Services
12.5.7.1.3.2. Nursing Services
12.5.7.1.3.3. Pediatric Therapy
12.5.7.1.3.3.1. Speech Therapy
12.5.7.1.3.3.2. Physical
Therapy
12.5.7.1.3.3.3. Others
12.5.7.1.3.4. Others
12.5.7.2. Benelux Union
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.2.1. Neonates (Below 28 days)
12.5.7.2.2. Infants (29 days to less than 2 years)
12.5.7.2.3. Children (2 years to less than 12 years)
12.5.7.2.4. Adolescents (12 years to less than 21 years)
12.5.7.3. Benelux Union
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.5.7.3.1. Online
12.5.7.3.2. Offline
12.5.7.3.2.1. Pharmacy and Drug
Stores
12.5.7.3.2.2. Specialty Stores
12.5.7.3.2.3. Hospitals and
Clinics
12.5.7.3.2.4. Others
12.5.7.4. Benelux Union
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of Europe
12.5.8.1. Rest of Europe
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.8.1.1. Drugs
12.5.8.1.1.1. General
Anaesthetics and Oxygen
12.5.8.1.1.2. Pain and
Palliative Care
12.5.8.1.1.3. Antiallergics
12.5.8.1.1.4. Antidotes
12.5.8.1.1.5. Anticonvulsants/
Antiepileptics
12.5.8.1.1.6. Anti-Infective
Medicines
12.5.8.1.1.6.1. Anthelminthics
12.5.8.1.1.6.2. Antibacterials
12.5.8.1.1.6.3. Antifungal
Medicines
12.5.8.1.1.6.4. Antiviral
Medicines
12.5.8.1.1.6.5. Antiprotozoal
Medicines
12.5.8.1.1.6.6. Others
12.5.8.1.1.7. Antimigraine
Medicines
12.5.8.1.1.8. Immunomodulators
and Antineoplastics
12.5.8.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
12.5.8.1.1.10. Cardiovascular
Medicines
12.5.8.1.1.11. Dermatological
Medicines
12.5.8.1.1.12. Disinfectants
and Antiseptics
12.5.8.1.1.13. Gastrointestinal
Medicines
12.5.8.1.1.14. Endocrine
Disorders Medicines
12.5.8.1.1.15. Immunologicals
12.5.8.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
12.5.8.1.2. Devices/Equipment
12.5.8.1.2.1. In Vitro
Diagnostic (IVD) Devices
12.5.8.1.2.2. Diagnostic
Imaging Devices
12.5.8.1.2.3. Anesthesia and
Respiratory Care Devices
12.5.8.1.2.4. Cardiology
Devices
12.5.8.1.2.5. Orthopaedic Devices
12.5.8.1.2.6. Telemedicine
12.5.8.1.2.7. Monitoring
Devices
12.5.8.1.2.7.1. Blood Pressure
12.5.8.1.2.7.2. Pulse Oximetry
12.5.8.1.2.7.3. Temperature
Monitoring
12.5.8.1.2.7.4. Others
12.5.8.1.2.8. Others
12.5.8.1.3. Services
12.5.8.1.3.1. Pediatric
Surgical Services
12.5.8.1.3.2. Nursing Services
12.5.8.1.3.3. Pediatric Therapy
12.5.8.1.3.3.1. Speech Therapy
12.5.8.1.3.3.2. Physical
Therapy
12.5.8.1.3.3.3. Others
12.5.8.1.3.4. Others
12.5.8.2. Rest of Europe
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.5.8.2.1. Neonates (Below 28 days)
12.5.8.2.2. Infants (29 days to less than 2 years)
12.5.8.2.3. Children (2 years to less than 12 years)
12.5.8.2.4. Adolescents (12 years to less than 21 years)
12.5.8.3. Rest of Europe
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.5.8.3.1. Online
12.5.8.3.2. Offline
12.5.8.3.2.1. Pharmacy and Drug
Stores
12.5.8.3.2.2. Specialty Stores
12.5.8.3.2.3. Hospitals and
Clinics
12.5.8.3.2.4. Others
12.6. Key Segment for
Channeling Investments
12.6.1. By Country
12.6.2. By Offering
12.6.3. By Application
12.6.4. By Distribution Channel
13. Asia Pacific Pediatric Healthcare Market Analysis and
Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Asia Pacific Pediatric
Healthcare Market Revenue (US$ Mn)
13.2. Asia Pacific Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Drugs
13.2.1.1. General Anaesthetics
and Oxygen
13.2.1.2. Pain and Palliative
Care
13.2.1.3. Antiallergics
13.2.1.4. Antidotes
13.2.1.5. Anticonvulsants/
Antiepileptics
13.2.1.6. Anti-Infective
Medicines
13.2.1.6.1. Anthelminthics
13.2.1.6.2. Antibacterials
13.2.1.6.3. Antifungal Medicines
13.2.1.6.4. Antiviral Medicines
13.2.1.6.5. Antiprotozoal Medicines
13.2.1.6.6. Others
13.2.1.7. Antimigraine
Medicines
13.2.1.8. Immunomodulators and
Antineoplastics
13.2.1.9. Medicines Affecting
the Blood (Antianaemia Medicines, Coagulation, etc.)
13.2.1.10. Cardiovascular
Medicines
13.2.1.11. Dermatological
Medicines
13.2.1.12. Disinfectants and
Antiseptics
13.2.1.13. Gastrointestinal
Medicines
13.2.1.14. Endocrine Disorders
Medicines
13.2.1.15. Immunologicals
13.2.1.16. Others (Diagnostic
Agents, Respiratory Tract Medicines, Etc.)
13.2.2. Devices/Equipment
13.2.2.1. In Vitro Diagnostic
(IVD) Devices
13.2.2.2. Diagnostic Imaging
Devices
13.2.2.3. Anesthesia and Respiratory
Care Devices
13.2.2.4. Cardiology Devices
13.2.2.5. Orthopaedic Devices
13.2.2.6. Telemedicine
13.2.2.7. Monitoring Devices
13.2.2.7.1. Blood Pressure
13.2.2.7.2. Pulse Oximetry
13.2.2.7.3. Temperature Monitoring
13.2.2.7.4. Others
13.2.2.8. Others
13.2.3. Services
13.2.3.1. Pediatric Surgical
Services
13.2.3.2. Nursing Services
13.2.3.3. Pediatric Therapy
13.2.3.3.1. Speech Therapy
13.2.3.3.2. Physical Therapy
13.2.3.3.3. Others
13.2.3.4. Others
13.3. Asia Pacific Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1. Neonates (Below 28
days)
13.3.2. Infants (29 days to
less than 2 years)
13.3.3. Children (2 years to
less than 12 years)
13.3.4. Adolescents (12 years
to less than 21 years)
13.4. Asia Pacific Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.4.1. Online
13.4.2. Offline
13.4.2.1. Pharmacy and Drug
Stores
13.4.2.2. Specialty Stores
13.4.2.3. Hospitals and Clinics
13.4.2.4. Others
13.5. Asia Pacific Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.1.1.1. Drugs
13.5.1.1.1.1. General
Anaesthetics and Oxygen
13.5.1.1.1.2. Pain and
Palliative Care
13.5.1.1.1.3. Antiallergics
13.5.1.1.1.4. Antidotes
13.5.1.1.1.5. Anticonvulsants/
Antiepileptics
13.5.1.1.1.6. Anti-Infective
Medicines
13.5.1.1.1.6.1. Anthelminthics
13.5.1.1.1.6.2. Antibacterials
13.5.1.1.1.6.3. Antifungal
Medicines
13.5.1.1.1.6.4. Antiviral
Medicines
13.5.1.1.1.6.5. Antiprotozoal
Medicines
13.5.1.1.1.6.6. Others
13.5.1.1.1.7. Antimigraine
Medicines
13.5.1.1.1.8. Immunomodulators
and Antineoplastics
13.5.1.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
13.5.1.1.1.10. Cardiovascular
Medicines
13.5.1.1.1.11. Dermatological
Medicines
13.5.1.1.1.12. Disinfectants
and Antiseptics
13.5.1.1.1.13. Gastrointestinal
Medicines
13.5.1.1.1.14. Endocrine
Disorders Medicines
13.5.1.1.1.15. Immunologicals
13.5.1.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
13.5.1.1.2. Devices/Equipment
13.5.1.1.2.1. In Vitro
Diagnostic (IVD) Devices
13.5.1.1.2.2. Diagnostic
Imaging Devices
13.5.1.1.2.3. Anesthesia and
Respiratory Care Devices
13.5.1.1.2.4. Cardiology
Devices
13.5.1.1.2.5. Orthopaedic Devices
13.5.1.1.2.6. Telemedicine
13.5.1.1.2.7. Monitoring
Devices
13.5.1.1.2.7.1. Blood Pressure
13.5.1.1.2.7.2. Pulse Oximetry
13.5.1.1.2.7.3. Temperature
Monitoring
13.5.1.1.2.7.4. Others
13.5.1.1.2.8. Others
13.5.1.1.3. Services
13.5.1.1.3.1. Pediatric
Surgical Services
13.5.1.1.3.2. Nursing Services
13.5.1.1.3.3. Pediatric Therapy
13.5.1.1.3.3.1. Speech Therapy
13.5.1.1.3.3.2. Physical
Therapy
13.5.1.1.3.3.3. Others
13.5.1.1.3.4. Others
13.5.1.2. China Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1. Neonates (Below 28 days)
13.5.1.2.2. Infants (29 days to less than 2 years)
13.5.1.2.3. Children (2 years to less than 12 years)
13.5.1.2.4. Adolescents (12 years to less than 21 years)
13.5.1.3. China Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.1.3.1. Online
13.5.1.3.2. Offline
13.5.1.3.2.1. Pharmacy and Drug
Stores
13.5.1.3.2.2. Specialty Stores
13.5.1.3.2.3. Hospitals and Clinics
13.5.1.3.2.4. Others
13.5.2. Japan
13.5.2.1. Japan Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.2.1.1. Drugs
13.5.2.1.1.1. General
Anaesthetics and Oxygen
13.5.2.1.1.2. Pain and
Palliative Care
13.5.2.1.1.3. Antiallergics
13.5.2.1.1.4. Antidotes
13.5.2.1.1.5. Anticonvulsants/
Antiepileptics
13.5.2.1.1.6. Anti-Infective
Medicines
13.5.2.1.1.6.1. Anthelminthics
13.5.2.1.1.6.2. Antibacterials
13.5.2.1.1.6.3. Antifungal
Medicines
13.5.2.1.1.6.4. Antiviral
Medicines
13.5.2.1.1.6.5. Antiprotozoal
Medicines
13.5.2.1.1.6.6. Others
13.5.2.1.1.7. Antimigraine
Medicines
13.5.2.1.1.8. Immunomodulators
and Antineoplastics
13.5.2.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
13.5.2.1.1.10. Cardiovascular
Medicines
13.5.2.1.1.11. Dermatological
Medicines
13.5.2.1.1.12. Disinfectants
and Antiseptics
13.5.2.1.1.13. Gastrointestinal
Medicines
13.5.2.1.1.14. Endocrine
Disorders Medicines
13.5.2.1.1.15. Immunologicals
13.5.2.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
13.5.2.1.2. Devices/Equipment
13.5.2.1.2.1. In Vitro
Diagnostic (IVD) Devices
13.5.2.1.2.2. Diagnostic
Imaging Devices
13.5.2.1.2.3. Anesthesia and
Respiratory Care Devices
13.5.2.1.2.4. Cardiology
Devices
13.5.2.1.2.5. Orthopaedic Devices
13.5.2.1.2.6. Telemedicine
13.5.2.1.2.7. Monitoring
Devices
13.5.2.1.2.7.1. Blood Pressure
13.5.2.1.2.7.2. Pulse Oximetry
13.5.2.1.2.7.3. Temperature
Monitoring
13.5.2.1.2.7.4. Others
13.5.2.1.2.8. Others
13.5.2.1.3. Services
13.5.2.1.3.1. Pediatric
Surgical Services
13.5.2.1.3.2. Nursing Services
13.5.2.1.3.3. Pediatric Therapy
13.5.2.1.3.3.1. Speech Therapy
13.5.2.1.3.3.2. Physical
Therapy
13.5.2.1.3.3.3. Others
13.5.2.1.3.4. Others
13.5.2.2. Japan Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1. Neonates (Below 28 days)
13.5.2.2.2. Infants (29 days to less than 2 years)
13.5.2.2.3. Children (2 years to less than 12 years)
13.5.2.2.4. Adolescents (12 years to less than 21 years)
13.5.2.3. Japan Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.2.3.1. Online
13.5.2.3.2. Offline
13.5.2.3.2.1. Pharmacy and Drug
Stores
13.5.2.3.2.2. Specialty Stores
13.5.2.3.2.3. Hospitals and
Clinics
13.5.2.3.2.4. Others
13.5.3. India
13.5.3.1. India Pediatric Healthcare
Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.3.1.1. Drugs
13.5.3.1.1.1. General
Anaesthetics and Oxygen
13.5.3.1.1.2. Pain and
Palliative Care
13.5.3.1.1.3. Antiallergics
13.5.3.1.1.4. Antidotes
13.5.3.1.1.5. Anticonvulsants/
Antiepileptics
13.5.3.1.1.6. Anti-Infective
Medicines
13.5.3.1.1.6.1. Anthelminthics
13.5.3.1.1.6.2. Antibacterials
13.5.3.1.1.6.3. Antifungal
Medicines
13.5.3.1.1.6.4. Antiviral
Medicines
13.5.3.1.1.6.5. Antiprotozoal
Medicines
13.5.3.1.1.6.6. Others
13.5.3.1.1.7. Antimigraine
Medicines
13.5.3.1.1.8. Immunomodulators
and Antineoplastics
13.5.3.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
13.5.3.1.1.10. Cardiovascular
Medicines
13.5.3.1.1.11. Dermatological
Medicines
13.5.3.1.1.12. Disinfectants
and Antiseptics
13.5.3.1.1.13. Gastrointestinal
Medicines
13.5.3.1.1.14. Endocrine
Disorders Medicines
13.5.3.1.1.15. Immunologicals
13.5.3.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
13.5.3.1.2. Devices/Equipment
13.5.3.1.2.1. In Vitro
Diagnostic (IVD) Devices
13.5.3.1.2.2. Diagnostic
Imaging Devices
13.5.3.1.2.3. Anesthesia and
Respiratory Care Devices
13.5.3.1.2.4. Cardiology
Devices
13.5.3.1.2.5. Orthopaedic Devices
13.5.3.1.2.6. Telemedicine
13.5.3.1.2.7. Monitoring
Devices
13.5.3.1.2.7.1. Blood Pressure
13.5.3.1.2.7.2. Pulse Oximetry
13.5.3.1.2.7.3. Temperature
Monitoring
13.5.3.1.2.7.4. Others
13.5.3.1.2.8. Others
13.5.3.1.3. Services
13.5.3.1.3.1. Pediatric
Surgical Services
13.5.3.1.3.2. Nursing Services
13.5.3.1.3.3. Pediatric Therapy
13.5.3.1.3.3.1. Speech Therapy
13.5.3.1.3.3.2. Physical
Therapy
13.5.3.1.3.3.3. Others
13.5.3.1.3.4. Others
13.5.3.2. India Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1. Neonates (Below 28 days)
13.5.3.2.2. Infants (29 days to less than 2 years)
13.5.3.2.3. Children (2 years to less than 12 years)
13.5.3.2.4. Adolescents (12 years to less than 21 years)
13.5.3.3. India Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.3.3.1. Online
13.5.3.3.2. Offline
13.5.3.3.2.1. Pharmacy and Drug
Stores
13.5.3.3.2.2. Specialty Stores
13.5.3.3.2.3. Hospitals and
Clinics
13.5.3.3.2.4. Others
13.5.4. New Zealand
13.5.4.1. New Zealand Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.4.1.1. Drugs
13.5.4.1.1.1. General
Anaesthetics and Oxygen
13.5.4.1.1.2. Pain and
Palliative Care
13.5.4.1.1.3. Antiallergics
13.5.4.1.1.4. Antidotes
13.5.4.1.1.5. Anticonvulsants/
Antiepileptics
13.5.4.1.1.6. Anti-Infective
Medicines
13.5.4.1.1.6.1. Anthelminthics
13.5.4.1.1.6.2. Antibacterials
13.5.4.1.1.6.3. Antifungal
Medicines
13.5.4.1.1.6.4. Antiviral
Medicines
13.5.4.1.1.6.5. Antiprotozoal
Medicines
13.5.4.1.1.6.6. Others
13.5.4.1.1.7. Antimigraine
Medicines
13.5.4.1.1.8. Immunomodulators
and Antineoplastics
13.5.4.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
13.5.4.1.1.10. Cardiovascular
Medicines
13.5.4.1.1.11. Dermatological
Medicines
13.5.4.1.1.12. Disinfectants
and Antiseptics
13.5.4.1.1.13. Gastrointestinal
Medicines
13.5.4.1.1.14. Endocrine
Disorders Medicines
13.5.4.1.1.15. Immunologicals
13.5.4.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
13.5.4.1.2. Devices/Equipment
13.5.4.1.2.1. In Vitro
Diagnostic (IVD) Devices
13.5.4.1.2.2. Diagnostic
Imaging Devices
13.5.4.1.2.3. Anesthesia and
Respiratory Care Devices
13.5.4.1.2.4. Cardiology
Devices
13.5.4.1.2.5. Orthopaedic Devices
13.5.4.1.2.6. Telemedicine
13.5.4.1.2.7. Monitoring
Devices
13.5.4.1.2.7.1. Blood Pressure
13.5.4.1.2.7.2. Pulse Oximetry
13.5.4.1.2.7.3. Temperature
Monitoring
13.5.4.1.2.7.4. Others
13.5.4.1.2.8. Others
13.5.4.1.3. Services
13.5.4.1.3.1. Pediatric
Surgical Services
13.5.4.1.3.2. Nursing Services
13.5.4.1.3.3. Pediatric Therapy
13.5.4.1.3.3.1. Speech Therapy
13.5.4.1.3.3.2. Physical
Therapy
13.5.4.1.3.3.3. Others
13.5.4.1.3.4. Others
13.5.4.2. New Zealand Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.5.4.2.1. Neonates (Below 28 days)
13.5.4.2.2. Infants (29 days to less than 2 years)
13.5.4.2.3. Children (2 years to less than 12 years)
13.5.4.2.4. Adolescents (12 years to less than 21 years)
13.5.4.3. New Zealand Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.4.3.1. Online
13.5.4.3.2. Offline
13.5.4.3.2.1. Pharmacy and Drug
Stores
13.5.4.3.2.2. Specialty Stores
13.5.4.3.2.3. Hospitals and
Clinics
13.5.4.3.2.4. Others
13.5.5. Australia
13.5.5.1. Australia Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.5.1.1. Drugs
13.5.5.1.1.1. General
Anaesthetics and Oxygen
13.5.5.1.1.2. Pain and
Palliative Care
13.5.5.1.1.3. Antiallergics
13.5.5.1.1.4. Antidotes
13.5.5.1.1.5. Anticonvulsants/
Antiepileptics
13.5.5.1.1.6. Anti-Infective
Medicines
13.5.5.1.1.6.1. Anthelminthics
13.5.5.1.1.6.2. Antibacterials
13.5.5.1.1.6.3. Antifungal
Medicines
13.5.5.1.1.6.4. Antiviral
Medicines
13.5.5.1.1.6.5. Antiprotozoal
Medicines
13.5.5.1.1.6.6. Others
13.5.5.1.1.7. Antimigraine
Medicines
13.5.5.1.1.8. Immunomodulators
and Antineoplastics
13.5.5.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
13.5.5.1.1.10. Cardiovascular
Medicines
13.5.5.1.1.11. Dermatological
Medicines
13.5.5.1.1.12. Disinfectants
and Antiseptics
13.5.5.1.1.13. Gastrointestinal
Medicines
13.5.5.1.1.14. Endocrine
Disorders Medicines
13.5.5.1.1.15. Immunologicals
13.5.5.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
13.5.5.1.2. Devices/Equipment
13.5.5.1.2.1. In Vitro
Diagnostic (IVD) Devices
13.5.5.1.2.2. Diagnostic
Imaging Devices
13.5.5.1.2.3. Anesthesia and
Respiratory Care Devices
13.5.5.1.2.4. Cardiology
Devices
13.5.5.1.2.5. Orthopaedic Devices
13.5.5.1.2.6. Telemedicine
13.5.5.1.2.7. Monitoring
Devices
13.5.5.1.2.7.1. Blood Pressure
13.5.5.1.2.7.2. Pulse Oximetry
13.5.5.1.2.7.3. Temperature
Monitoring
13.5.5.1.2.7.4. Others
13.5.5.1.2.8. Others
13.5.5.1.3. Services
13.5.5.1.3.1. Pediatric
Surgical Services
13.5.5.1.3.2. Nursing Services
13.5.5.1.3.3. Pediatric Therapy
13.5.5.1.3.3.1. Speech Therapy
13.5.5.1.3.3.2. Physical
Therapy
13.5.5.1.3.3.3. Others
13.5.5.1.3.4. Others
13.5.5.2. Australia Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1. Neonates (Below 28 days)
13.5.5.2.2. Infants (29 days to less than 2 years)
13.5.5.2.3. Children (2 years to less than 12 years)
13.5.5.2.4. Adolescents (12 years to less than 21 years)
13.5.5.3. Australia Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.5.3.1. Online
13.5.5.3.2. Offline
13.5.5.3.2.1. Pharmacy and Drug
Stores
13.5.5.3.2.2. Specialty Stores
13.5.5.3.2.3. Hospitals and
Clinics
13.5.5.3.2.4. Others
13.5.6. South Korea
13.5.6.1. South Korea Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.6.1.1. Drugs
13.5.6.1.1.1. General
Anaesthetics and Oxygen
13.5.6.1.1.2. Pain and
Palliative Care
13.5.6.1.1.3. Antiallergics
13.5.6.1.1.4. Antidotes
13.5.6.1.1.5. Anticonvulsants/
Antiepileptics
13.5.6.1.1.6. Anti-Infective
Medicines
13.5.6.1.1.6.1. Anthelminthics
13.5.6.1.1.6.2. Antibacterials
13.5.6.1.1.6.3. Antifungal
Medicines
13.5.6.1.1.6.4. Antiviral
Medicines
13.5.6.1.1.6.5. Antiprotozoal
Medicines
13.5.6.1.1.6.6. Others
13.5.6.1.1.7. Antimigraine
Medicines
13.5.6.1.1.8. Immunomodulators
and Antineoplastics
13.5.6.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
13.5.6.1.1.10. Cardiovascular
Medicines
13.5.6.1.1.11. Dermatological
Medicines
13.5.6.1.1.12. Disinfectants
and Antiseptics
13.5.6.1.1.13. Gastrointestinal
Medicines
13.5.6.1.1.14. Endocrine
Disorders Medicines
13.5.6.1.1.15. Immunologicals
13.5.6.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
13.5.6.1.2. Devices/Equipment
13.5.6.1.2.1. In Vitro
Diagnostic (IVD) Devices
13.5.6.1.2.2. Diagnostic
Imaging Devices
13.5.6.1.2.3. Anesthesia and
Respiratory Care Devices
13.5.6.1.2.4. Cardiology Devices
13.5.6.1.2.5. Orthopaedic Devices
13.5.6.1.2.6. Telemedicine
13.5.6.1.2.7. Monitoring
Devices
13.5.6.1.2.7.1. Blood Pressure
13.5.6.1.2.7.2. Pulse Oximetry
13.5.6.1.2.7.3. Temperature
Monitoring
13.5.6.1.2.7.4. Others
13.5.6.1.2.8. Others
13.5.6.1.3. Services
13.5.6.1.3.1. Pediatric
Surgical Services
13.5.6.1.3.2. Nursing Services
13.5.6.1.3.3. Pediatric Therapy
13.5.6.1.3.3.1. Speech Therapy
13.5.6.1.3.3.2. Physical
Therapy
13.5.6.1.3.3.3. Others
13.5.6.1.3.4. Others
13.5.6.2. South Korea Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.2.1. Neonates (Below 28 days)
13.5.6.2.2. Infants (29 days to less than 2 years)
13.5.6.2.3. Children (2 years to less than 12 years)
13.5.6.2.4. Adolescents (12 years to less than 21 years)
13.5.6.3. South Korea Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.6.3.1. Online
13.5.6.3.2. Offline
13.5.6.3.2.1. Pharmacy and Drug
Stores
13.5.6.3.2.2. Specialty Stores
13.5.6.3.2.3. Hospitals and
Clinics
13.5.6.3.2.4. Others
13.5.7. Southeast Asia
13.5.7.1. Southeast Asia
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.7.1.1. Drugs
13.5.7.1.1.1. General
Anaesthetics and Oxygen
13.5.7.1.1.2. Pain and
Palliative Care
13.5.7.1.1.3. Antiallergics
13.5.7.1.1.4. Antidotes
13.5.7.1.1.5. Anticonvulsants/
Antiepileptics
13.5.7.1.1.6. Anti-Infective
Medicines
13.5.7.1.1.6.1. Anthelminthics
13.5.7.1.1.6.2. Antibacterials
13.5.7.1.1.6.3. Antifungal
Medicines
13.5.7.1.1.6.4. Antiviral Medicines
13.5.7.1.1.6.5. Antiprotozoal
Medicines
13.5.7.1.1.6.6. Others
13.5.7.1.1.7. Antimigraine
Medicines
13.5.7.1.1.8. Immunomodulators
and Antineoplastics
13.5.7.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
13.5.7.1.1.10. Cardiovascular
Medicines
13.5.7.1.1.11. Dermatological
Medicines
13.5.7.1.1.12. Disinfectants
and Antiseptics
13.5.7.1.1.13. Gastrointestinal
Medicines
13.5.7.1.1.14. Endocrine
Disorders Medicines
13.5.7.1.1.15. Immunologicals
13.5.7.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
13.5.7.1.2. Devices/Equipment
13.5.7.1.2.1. In Vitro
Diagnostic (IVD) Devices
13.5.7.1.2.2. Diagnostic
Imaging Devices
13.5.7.1.2.3. Anesthesia and
Respiratory Care Devices
13.5.7.1.2.4. Cardiology
Devices
13.5.7.1.2.5. Orthopaedic Devices
13.5.7.1.2.6. Telemedicine
13.5.7.1.2.7. Monitoring
Devices
13.5.7.1.2.7.1. Blood Pressure
13.5.7.1.2.7.2. Pulse Oximetry
13.5.7.1.2.7.3. Temperature
Monitoring
13.5.7.1.2.7.4. Others
13.5.7.1.2.8. Others
13.5.7.1.3. Services
13.5.7.1.3.1. Pediatric
Surgical Services
13.5.7.1.3.2. Nursing Services
13.5.7.1.3.3. Pediatric Therapy
13.5.7.1.3.3.1. Speech Therapy
13.5.7.1.3.3.2. Physical
Therapy
13.5.7.1.3.3.3. Others
13.5.7.1.3.4. Others
13.5.7.2. Southeast Asia
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1. Neonates (Below 28 days)
13.5.7.2.2. Infants (29 days to less than 2 years)
13.5.7.2.3. Children (2 years to less than 12 years)
13.5.7.2.4. Adolescents (12 years to less than 21 years)
13.5.7.3. Southeast Asia
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.5.7.3.1. Online
13.5.7.3.2. Offline
13.5.7.3.2.1. Pharmacy and Drug
Stores
13.5.7.3.2.2. Specialty Stores
13.5.7.3.2.3. Hospitals and
Clinics
13.5.7.3.2.4. Others
13.5.7.4. Southeast Asia
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1. Rest of Asia Pacific
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.8.1.1. Drugs
13.5.8.1.1.1. General
Anaesthetics and Oxygen
13.5.8.1.1.2. Pain and
Palliative Care
13.5.8.1.1.3. Antiallergics
13.5.8.1.1.4. Antidotes
13.5.8.1.1.5. Anticonvulsants/
Antiepileptics
13.5.8.1.1.6. Anti-Infective
Medicines
13.5.8.1.1.6.1. Anthelminthics
13.5.8.1.1.6.2. Antibacterials
13.5.8.1.1.6.3. Antifungal
Medicines
13.5.8.1.1.6.4. Antiviral
Medicines
13.5.8.1.1.6.5. Antiprotozoal
Medicines
13.5.8.1.1.6.6. Others
13.5.8.1.1.7. Antimigraine
Medicines
13.5.8.1.1.8. Immunomodulators
and Antineoplastics
13.5.8.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
13.5.8.1.1.10. Cardiovascular
Medicines
13.5.8.1.1.11. Dermatological
Medicines
13.5.8.1.1.12. Disinfectants
and Antiseptics
13.5.8.1.1.13. Gastrointestinal
Medicines
13.5.8.1.1.14. Endocrine
Disorders Medicines
13.5.8.1.1.15. Immunologicals
13.5.8.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
13.5.8.1.2. Devices/Equipment
13.5.8.1.2.1. In Vitro
Diagnostic (IVD) Devices
13.5.8.1.2.2. Diagnostic
Imaging Devices
13.5.8.1.2.3. Anesthesia and
Respiratory Care Devices
13.5.8.1.2.4. Cardiology
Devices
13.5.8.1.2.5. Orthopaedic Devices
13.5.8.1.2.6. Telemedicine
13.5.8.1.2.7. Monitoring
Devices
13.5.8.1.2.7.1. Blood Pressure
13.5.8.1.2.7.2. Pulse Oximetry
13.5.8.1.2.7.3. Temperature
Monitoring
13.5.8.1.2.7.4. Others
13.5.8.1.2.8. Others
13.5.8.1.3. Services
13.5.8.1.3.1. Pediatric
Surgical Services
13.5.8.1.3.2. Nursing Services
13.5.8.1.3.3. Pediatric Therapy
13.5.8.1.3.3.1. Speech Therapy
13.5.8.1.3.3.2. Physical
Therapy
13.5.8.1.3.3.3. Others
13.5.8.1.3.4. Others
13.5.8.2. Rest of Asia Pacific
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.5.8.2.1. Neonates (Below 28 days)
13.5.8.2.2. Infants (29 days to less than 2 years)
13.5.8.2.3. Children (2 years to less than 12 years)
13.5.8.2.4. Adolescents (12 years to less than 21 years)
13.5.8.3. Rest of Asia Pacific
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.5.8.3.1. Online
13.5.8.3.2. Offline
13.5.8.3.2.1. Pharmacy and Drug
Stores
13.5.8.3.2.2. Specialty Stores
13.5.8.3.2.3. Hospitals and
Clinics
13.5.8.3.2.4. Others
13.6. Key Segment for
Channeling Investments
13.6.1. By Country
13.6.2. By Offering
13.6.3. By Application
13.6.4. By Distribution Channel
14. Middle East and Africa Pediatric Healthcare Market Analysis
and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Middle East and Africa
Pediatric Healthcare Market Revenue (US$ Mn)
14.2. Middle East and Africa
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
14.2.1. Drugs
14.2.1.1. General Anaesthetics
and Oxygen
14.2.1.2. Pain and Palliative
Care
14.2.1.3. Antiallergics
14.2.1.4. Antidotes
14.2.1.5. Anticonvulsants/
Antiepileptics
14.2.1.6. Anti-Infective
Medicines
14.2.1.6.1. Anthelminthics
14.2.1.6.2. Antibacterials
14.2.1.6.3. Antifungal Medicines
14.2.1.6.4. Antiviral Medicines
14.2.1.6.5. Antiprotozoal Medicines
14.2.1.6.6. Others
14.2.1.7. Antimigraine
Medicines
14.2.1.8. Immunomodulators and Antineoplastics
14.2.1.9. Medicines Affecting
the Blood (Antianaemia Medicines, Coagulation, etc.)
14.2.1.10. Cardiovascular
Medicines
14.2.1.11. Dermatological
Medicines
14.2.1.12. Disinfectants and
Antiseptics
14.2.1.13. Gastrointestinal
Medicines
14.2.1.14. Endocrine Disorders
Medicines
14.2.1.15. Immunologicals
14.2.1.16. Others (Diagnostic
Agents, Respiratory Tract Medicines, Etc.)
14.2.2. Devices/Equipment
14.2.2.1. In Vitro Diagnostic
(IVD) Devices
14.2.2.2. Diagnostic Imaging
Devices
14.2.2.3. Anesthesia and
Respiratory Care Devices
14.2.2.4. Cardiology Devices
14.2.2.5. Orthopaedic Devices
14.2.2.6. Telemedicine
14.2.2.7. Monitoring Devices
14.2.2.7.1. Blood Pressure
14.2.2.7.2. Pulse Oximetry
14.2.2.7.3. Temperature Monitoring
14.2.2.7.4. Others
14.2.2.8. Others
14.2.3. Services
14.2.3.1. Pediatric Surgical
Services
14.2.3.2. Nursing Services
14.2.3.3. Pediatric Therapy
14.2.3.3.1. Speech Therapy
14.2.3.3.2. Physical Therapy
14.2.3.3.3. Others
14.2.3.4. Others
14.3. Middle East and Africa
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Neonates (Below 28
days)
14.3.2. Infants (29 days to
less than 2 years)
14.3.3. Children (2 years to
less than 12 years)
14.3.4. Adolescents (12 years
to less than 21 years)
14.4. Middle East and Africa
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.4.1. Online
14.4.2. Offline
14.4.2.1. Pharmacy and Drug
Stores
14.4.2.2. Specialty Stores
14.4.2.3. Hospitals and Clinics
14.4.2.4. Others
14.5. Middle East and Africa
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi Arabia
14.5.1.1. Saudi Arabia
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.1.1.1. Drugs
14.5.1.1.1.1. General
Anaesthetics and Oxygen
14.5.1.1.1.2. Pain and
Palliative Care
14.5.1.1.1.3. Antiallergics
14.5.1.1.1.4. Antidotes
14.5.1.1.1.5. Anticonvulsants/
Antiepileptics
14.5.1.1.1.6. Anti-Infective
Medicines
14.5.1.1.1.6.1. Anthelminthics
14.5.1.1.1.6.2. Antibacterials
14.5.1.1.1.6.3. Antifungal
Medicines
14.5.1.1.1.6.4. Antiviral
Medicines
14.5.1.1.1.6.5. Antiprotozoal
Medicines
14.5.1.1.1.6.6. Others
14.5.1.1.1.7. Antimigraine
Medicines
14.5.1.1.1.8. Immunomodulators
and Antineoplastics
14.5.1.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
14.5.1.1.1.10. Cardiovascular
Medicines
14.5.1.1.1.11. Dermatological
Medicines
14.5.1.1.1.12. Disinfectants
and Antiseptics
14.5.1.1.1.13. Gastrointestinal
Medicines
14.5.1.1.1.14. Endocrine
Disorders Medicines
14.5.1.1.1.15. Immunologicals
14.5.1.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
14.5.1.1.2. Devices/Equipment
14.5.1.1.2.1. In Vitro
Diagnostic (IVD) Devices
14.5.1.1.2.2. Diagnostic
Imaging Devices
14.5.1.1.2.3. Anesthesia and
Respiratory Care Devices
14.5.1.1.2.4. Cardiology
Devices
14.5.1.1.2.5. Orthopaedic Devices
14.5.1.1.2.6. Telemedicine
14.5.1.1.2.7. Monitoring
Devices
14.5.1.1.2.7.1. Blood Pressure
14.5.1.1.2.7.2. Pulse Oximetry
14.5.1.1.2.7.3. Temperature
Monitoring
14.5.1.1.2.7.4. Others
14.5.1.1.2.8. Others
14.5.1.1.3. Services
14.5.1.1.3.1. Pediatric
Surgical Services
14.5.1.1.3.2. Nursing Services
14.5.1.1.3.3. Pediatric Therapy
14.5.1.1.3.3.1. Speech Therapy
14.5.1.1.3.3.2. Physical
Therapy
14.5.1.1.3.3.3. Others
14.5.1.1.3.4. Others
14.5.1.2. Saudi Arabia
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.2.1. Neonates (Below 28 days)
14.5.1.2.2. Infants (29 days to less than 2 years)
14.5.1.2.3. Children (2 years to less than 12 years)
14.5.1.2.4. Adolescents (12 years to less than 21 years)
14.5.1.3. Saudi Arabia
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.5.1.3.1. Online
14.5.1.3.2. Offline
14.5.1.3.2.1. Pharmacy and Drug
Stores
14.5.1.3.2.2. Specialty Stores
14.5.1.3.2.3. Hospitals and
Clinics
14.5.1.3.2.4. Others
14.5.2. UAE
14.5.2.1. UAE Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.2.1.1. Drugs
14.5.2.1.1.1. General
Anaesthetics and Oxygen
14.5.2.1.1.2. Pain and
Palliative Care
14.5.2.1.1.3. Antiallergics
14.5.2.1.1.4. Antidotes
14.5.2.1.1.5. Anticonvulsants/
Antiepileptics
14.5.2.1.1.6. Anti-Infective
Medicines
14.5.2.1.1.6.1. Anthelminthics
14.5.2.1.1.6.2. Antibacterials
14.5.2.1.1.6.3. Antifungal
Medicines
14.5.2.1.1.6.4. Antiviral Medicines
14.5.2.1.1.6.5. Antiprotozoal
Medicines
14.5.2.1.1.6.6. Others
14.5.2.1.1.7. Antimigraine
Medicines
14.5.2.1.1.8. Immunomodulators
and Antineoplastics
14.5.2.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
14.5.2.1.1.10. Cardiovascular
Medicines
14.5.2.1.1.11. Dermatological
Medicines
14.5.2.1.1.12. Disinfectants
and Antiseptics
14.5.2.1.1.13. Gastrointestinal
Medicines
14.5.2.1.1.14. Endocrine
Disorders Medicines
14.5.2.1.1.15. Immunologicals
14.5.2.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
14.5.2.1.2. Devices/Equipment
14.5.2.1.2.1. In Vitro
Diagnostic (IVD) Devices
14.5.2.1.2.2. Diagnostic
Imaging Devices
14.5.2.1.2.3. Anesthesia and
Respiratory Care Devices
14.5.2.1.2.4. Cardiology
Devices
14.5.2.1.2.5. Orthopaedic Devices
14.5.2.1.2.6. Telemedicine
14.5.2.1.2.7. Monitoring
Devices
14.5.2.1.2.7.1. Blood Pressure
14.5.2.1.2.7.2. Pulse Oximetry
14.5.2.1.2.7.3. Temperature
Monitoring
14.5.2.1.2.7.4. Others
14.5.2.1.2.8. Others
14.5.2.1.3. Services
14.5.2.1.3.1. Pediatric
Surgical Services
14.5.2.1.3.2. Nursing Services
14.5.2.1.3.3. Pediatric Therapy
14.5.2.1.3.3.1. Speech Therapy
14.5.2.1.3.3.2. Physical Therapy
14.5.2.1.3.3.3. Others
14.5.2.1.3.4. Others
14.5.2.2. UAE Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1. Neonates (Below 28 days)
14.5.2.2.2. Infants (29 days to less than 2 years)
14.5.2.2.3. Children (2 years to less than 12 years)
14.5.2.2.4. Adolescents (12 years to less than 21 years)
14.5.2.3. UAE Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.5.2.3.1. Online
14.5.2.3.2. Offline
14.5.2.3.2.1. Pharmacy and Drug
Stores
14.5.2.3.2.2. Specialty Stores
14.5.2.3.2.3. Hospitals and
Clinics
14.5.2.3.2.4. Others
14.5.3. Egypt
14.5.3.1. Egypt Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.3.1.1. Drugs
14.5.3.1.1.1. General
Anaesthetics and Oxygen
14.5.3.1.1.2. Pain and
Palliative Care
14.5.3.1.1.3. Antiallergics
14.5.3.1.1.4. Antidotes
14.5.3.1.1.5. Anticonvulsants/
Antiepileptics
14.5.3.1.1.6. Anti-Infective
Medicines
14.5.3.1.1.6.1. Anthelminthics
14.5.3.1.1.6.2. Antibacterials
14.5.3.1.1.6.3. Antifungal
Medicines
14.5.3.1.1.6.4. Antiviral
Medicines
14.5.3.1.1.6.5. Antiprotozoal
Medicines
14.5.3.1.1.6.6. Others
14.5.3.1.1.7. Antimigraine
Medicines
14.5.3.1.1.8. Immunomodulators
and Antineoplastics
14.5.3.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
14.5.3.1.1.10. Cardiovascular
Medicines
14.5.3.1.1.11. Dermatological
Medicines
14.5.3.1.1.12. Disinfectants
and Antiseptics
14.5.3.1.1.13. Gastrointestinal
Medicines
14.5.3.1.1.14. Endocrine Disorders
Medicines
14.5.3.1.1.15. Immunologicals
14.5.3.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
14.5.3.1.2. Devices/Equipment
14.5.3.1.2.1. In Vitro
Diagnostic (IVD) Devices
14.5.3.1.2.2. Diagnostic
Imaging Devices
14.5.3.1.2.3. Anesthesia and
Respiratory Care Devices
14.5.3.1.2.4. Cardiology
Devices
14.5.3.1.2.5. Orthopaedic Devices
14.5.3.1.2.6. Telemedicine
14.5.3.1.2.7. Monitoring
Devices
14.5.3.1.2.7.1. Blood Pressure
14.5.3.1.2.7.2. Pulse Oximetry
14.5.3.1.2.7.3. Temperature
Monitoring
14.5.3.1.2.7.4. Others
14.5.3.1.2.8. Others
14.5.3.1.3. Services
14.5.3.1.3.1. Pediatric
Surgical Services
14.5.3.1.3.2. Nursing Services
14.5.3.1.3.3. Pediatric Therapy
14.5.3.1.3.3.1. Speech Therapy
14.5.3.1.3.3.2. Physical
Therapy
14.5.3.1.3.3.3. Others
14.5.3.1.3.4. Others
14.5.3.2. Egypt Pediatric Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1. Neonates (Below 28 days)
14.5.3.2.2. Infants (29 days to less than 2 years)
14.5.3.2.3. Children (2 years to less than 12 years)
14.5.3.2.4. Adolescents (12 years to less than 21 years)
14.5.3.3. Egypt Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.5.3.3.1. Online
14.5.3.3.2. Offline
14.5.3.3.2.1. Pharmacy and Drug
Stores
14.5.3.3.2.2. Specialty Stores
14.5.3.3.2.3. Hospitals and
Clinics
14.5.3.3.2.4. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.4.1.1. Drugs
14.5.4.1.1.1. General Anaesthetics
and Oxygen
14.5.4.1.1.2. Pain and
Palliative Care
14.5.4.1.1.3. Antiallergics
14.5.4.1.1.4. Antidotes
14.5.4.1.1.5. Anticonvulsants/
Antiepileptics
14.5.4.1.1.6. Anti-Infective
Medicines
14.5.4.1.1.6.1. Anthelminthics
14.5.4.1.1.6.2. Antibacterials
14.5.4.1.1.6.3. Antifungal
Medicines
14.5.4.1.1.6.4. Antiviral
Medicines
14.5.4.1.1.6.5. Antiprotozoal
Medicines
14.5.4.1.1.6.6. Others
14.5.4.1.1.7. Antimigraine Medicines
14.5.4.1.1.8. Immunomodulators
and Antineoplastics
14.5.4.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
14.5.4.1.1.10. Cardiovascular
Medicines
14.5.4.1.1.11. Dermatological
Medicines
14.5.4.1.1.12. Disinfectants
and Antiseptics
14.5.4.1.1.13. Gastrointestinal
Medicines
14.5.4.1.1.14. Endocrine
Disorders Medicines
14.5.4.1.1.15. Immunologicals
14.5.4.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
14.5.4.1.2. Devices/Equipment
14.5.4.1.2.1. In Vitro
Diagnostic (IVD) Devices
14.5.4.1.2.2. Diagnostic
Imaging Devices
14.5.4.1.2.3. Anesthesia and
Respiratory Care Devices
14.5.4.1.2.4. Cardiology
Devices
14.5.4.1.2.5. Orthopaedic Devices
14.5.4.1.2.6. Telemedicine
14.5.4.1.2.7. Monitoring
Devices
14.5.4.1.2.7.1. Blood Pressure
14.5.4.1.2.7.2. Pulse Oximetry
14.5.4.1.2.7.3. Temperature
Monitoring
14.5.4.1.2.7.4. Others
14.5.4.1.2.8. Others
14.5.4.1.3. Services
14.5.4.1.3.1. Pediatric
Surgical Services
14.5.4.1.3.2. Nursing Services
14.5.4.1.3.3. Pediatric Therapy
14.5.4.1.3.3.1. Speech Therapy
14.5.4.1.3.3.2. Physical
Therapy
14.5.4.1.3.3.3. Others
14.5.4.1.3.4. Others
14.5.4.2. Kuwait Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1. Neonates (Below 28 days)
14.5.4.2.2. Infants (29 days to less than 2 years)
14.5.4.2.3. Children (2 years to less than 12 years)
14.5.4.2.4. Adolescents (12 years to less than 21 years)
14.5.4.3. Kuwait Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.5.4.3.1. Online
14.5.4.3.2. Offline
14.5.4.3.2.1. Pharmacy and Drug
Stores
14.5.4.3.2.2. Specialty Stores
14.5.4.3.2.3. Hospitals and
Clinics
14.5.4.3.2.4. Others
14.5.5. South Africa
14.5.5.1. South Africa
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.5.1.1. Drugs
14.5.5.1.1.1. General
Anaesthetics and Oxygen
14.5.5.1.1.2. Pain and
Palliative Care
14.5.5.1.1.3. Antiallergics
14.5.5.1.1.4. Antidotes
14.5.5.1.1.5. Anticonvulsants/
Antiepileptics
14.5.5.1.1.6. Anti-Infective
Medicines
14.5.5.1.1.6.1. Anthelminthics
14.5.5.1.1.6.2. Antibacterials
14.5.5.1.1.6.3. Antifungal
Medicines
14.5.5.1.1.6.4. Antiviral
Medicines
14.5.5.1.1.6.5. Antiprotozoal
Medicines
14.5.5.1.1.6.6. Others
14.5.5.1.1.7. Antimigraine
Medicines
14.5.5.1.1.8. Immunomodulators
and Antineoplastics
14.5.5.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
14.5.5.1.1.10. Cardiovascular
Medicines
14.5.5.1.1.11. Dermatological
Medicines
14.5.5.1.1.12. Disinfectants
and Antiseptics
14.5.5.1.1.13. Gastrointestinal
Medicines
14.5.5.1.1.14. Endocrine
Disorders Medicines
14.5.5.1.1.15. Immunologicals
14.5.5.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
14.5.5.1.2. Devices/Equipment
14.5.5.1.2.1. In Vitro
Diagnostic (IVD) Devices
14.5.5.1.2.2. Diagnostic
Imaging Devices
14.5.5.1.2.3. Anesthesia and
Respiratory Care Devices
14.5.5.1.2.4. Cardiology
Devices
14.5.5.1.2.5. Orthopaedic Devices
14.5.5.1.2.6. Telemedicine
14.5.5.1.2.7. Monitoring Devices
14.5.5.1.2.7.1. Blood Pressure
14.5.5.1.2.7.2. Pulse Oximetry
14.5.5.1.2.7.3. Temperature
Monitoring
14.5.5.1.2.7.4. Others
14.5.5.1.2.8. Others
14.5.5.1.3. Services
14.5.5.1.3.1. Pediatric
Surgical Services
14.5.5.1.3.2. Nursing Services
14.5.5.1.3.3. Pediatric Therapy
14.5.5.1.3.3.1. Speech Therapy
14.5.5.1.3.3.2. Physical
Therapy
14.5.5.1.3.3.3. Others
14.5.5.1.3.4. Others
14.5.5.2. South Africa
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.2.1. Neonates (Below 28 days)
14.5.5.2.2. Infants (29 days to less than 2 years)
14.5.5.2.3. Children (2 years to less than 12 years)
14.5.5.2.4. Adolescents (12 years to less than 21 years)
14.5.5.3. South Africa
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.5.5.3.1. Online
14.5.5.3.2. Offline
14.5.5.3.2.1. Pharmacy and Drug
Stores
14.5.5.3.2.2. Specialty Stores
14.5.5.3.2.3. Hospitals and
Clinics
14.5.5.3.2.4. Others
14.5.6. Rest of Middle East
& Africa
14.5.6.1. Rest of Middle East
& Africa Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.6.1.1. Drugs
14.5.6.1.1.1. General
Anaesthetics and Oxygen
14.5.6.1.1.2. Pain and
Palliative Care
14.5.6.1.1.3. Antiallergics
14.5.6.1.1.4. Antidotes
14.5.6.1.1.5. Anticonvulsants/
Antiepileptics
14.5.6.1.1.6. Anti-Infective
Medicines
14.5.6.1.1.6.1. Anthelminthics
14.5.6.1.1.6.2. Antibacterials
14.5.6.1.1.6.3. Antifungal
Medicines
14.5.6.1.1.6.4. Antiviral
Medicines
14.5.6.1.1.6.5. Antiprotozoal Medicines
14.5.6.1.1.6.6. Others
14.5.6.1.1.7. Antimigraine
Medicines
14.5.6.1.1.8. Immunomodulators
and Antineoplastics
14.5.6.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
14.5.6.1.1.10. Cardiovascular
Medicines
14.5.6.1.1.11. Dermatological
Medicines
14.5.6.1.1.12. Disinfectants
and Antiseptics
14.5.6.1.1.13. Gastrointestinal
Medicines
14.5.6.1.1.14. Endocrine
Disorders Medicines
14.5.6.1.1.15. Immunologicals
14.5.6.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
14.5.6.1.2. Devices/Equipment
14.5.6.1.2.1. In Vitro
Diagnostic (IVD) Devices
14.5.6.1.2.2. Diagnostic
Imaging Devices
14.5.6.1.2.3. Anesthesia and
Respiratory Care Devices
14.5.6.1.2.4. Cardiology
Devices
14.5.6.1.2.5. Orthopaedic Devices
14.5.6.1.2.6. Telemedicine
14.5.6.1.2.7. Monitoring
Devices
14.5.6.1.2.7.1. Blood Pressure
14.5.6.1.2.7.2. Pulse Oximetry
14.5.6.1.2.7.3. Temperature
Monitoring
14.5.6.1.2.7.4. Others
14.5.6.1.2.8. Others
14.5.6.1.3. Services
14.5.6.1.3.1. Pediatric
Surgical Services
14.5.6.1.3.2. Nursing Services
14.5.6.1.3.3. Pediatric Therapy
14.5.6.1.3.3.1. Speech Therapy
14.5.6.1.3.3.2. Physical
Therapy
14.5.6.1.3.3.3. Others
14.5.6.1.3.4. Others
14.5.6.2. Rest of Middle East
& Africa Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.6.2.1. Neonates (Below 28 days)
14.5.6.2.2. Infants (29 days to less than 2 years)
14.5.6.2.3. Children (2 years to less than 12 years)
14.5.6.2.4. Adolescents (12 years to less than 21 years)
14.5.6.3. Rest of Middle East
& Africa Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.5.6.3.1. Online
14.5.6.3.2. Offline
14.5.6.3.2.1. Pharmacy and Drug
Stores
14.5.6.3.2.2. Specialty Stores
14.5.6.3.2.3. Hospitals and
Clinics
14.5.6.3.2.4. Others
14.6. Key Segment for
Channeling Investments
14.6.1. By Country
14.6.2. By Offering
14.6.3. By Application
14.6.4. By Distribution Channel
15. Latin America Pediatric Healthcare Market Analysis and
Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Latin America Pediatric
Healthcare Market Revenue (US$ Mn)
15.2. Latin America Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
15.2.1. Drugs
15.2.1.1. General Anaesthetics
and Oxygen
15.2.1.2. Pain and Palliative
Care
15.2.1.3. Antiallergics
15.2.1.4. Antidotes
15.2.1.5. Anticonvulsants/
Antiepileptics
15.2.1.6. Anti-Infective
Medicines
15.2.1.6.1. Anthelminthics
15.2.1.6.2. Antibacterials
15.2.1.6.3. Antifungal Medicines
15.2.1.6.4. Antiviral Medicines
15.2.1.6.5. Antiprotozoal Medicines
15.2.1.6.6. Others
15.2.1.7. Antimigraine
Medicines
15.2.1.8. Immunomodulators and
Antineoplastics
15.2.1.9. Medicines Affecting
the Blood (Antianaemia Medicines, Coagulation, etc.)
15.2.1.10. Cardiovascular
Medicines
15.2.1.11. Dermatological
Medicines
15.2.1.12. Disinfectants and
Antiseptics
15.2.1.13. Gastrointestinal
Medicines
15.2.1.14. Endocrine Disorders
Medicines
15.2.1.15. Immunologicals
15.2.1.16. Others (Diagnostic
Agents, Respiratory Tract Medicines, Etc.)
15.2.2. Devices/Equipment
15.2.2.1. In Vitro Diagnostic
(IVD) Devices
15.2.2.2. Diagnostic Imaging
Devices
15.2.2.3. Anesthesia and
Respiratory Care Devices
15.2.2.4. Cardiology Devices
15.2.2.5. Orthopaedic Devices
15.2.2.6. Telemedicine
15.2.2.7. Monitoring Devices
15.2.2.7.1. Blood Pressure
15.2.2.7.2. Pulse Oximetry
15.2.2.7.3. Temperature Monitoring
15.2.2.7.4. Others
15.2.2.8. Others
15.2.3. Services
15.2.3.1. Pediatric Surgical
Services
15.2.3.2. Nursing Services
15.2.3.3. Pediatric Therapy
15.2.3.3.1. Speech Therapy
15.2.3.3.2. Physical Therapy
15.2.3.3.3. Others
15.2.3.4. Others
15.3. Latin America Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1. Neonates (Below 28
days)
15.3.2. Infants (29 days to
less than 2 years)
15.3.3. Children (2 years to
less than 12 years)
15.3.4. Adolescents (12 years
to less than 21 years)
15.4. Latin America Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.4.1. Online
15.4.2. Offline
15.4.2.1. Pharmacy and Drug
Stores
15.4.2.2. Specialty Stores
15.4.2.3. Hospitals and Clinics
15.4.2.4. Others
15.5. Latin America Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.1.1.1. Drugs
15.5.1.1.1.1. General
Anaesthetics and Oxygen
15.5.1.1.1.2. Pain and
Palliative Care
15.5.1.1.1.3. Antiallergics
15.5.1.1.1.4. Antidotes
15.5.1.1.1.5. Anticonvulsants/
Antiepileptics
15.5.1.1.1.6. Anti-Infective
Medicines
15.5.1.1.1.6.1. Anthelminthics
15.5.1.1.1.6.2. Antibacterials
15.5.1.1.1.6.3. Antifungal
Medicines
15.5.1.1.1.6.4. Antiviral
Medicines
15.5.1.1.1.6.5. Antiprotozoal
Medicines
15.5.1.1.1.6.6. Others
15.5.1.1.1.7. Antimigraine
Medicines
15.5.1.1.1.8. Immunomodulators
and Antineoplastics
15.5.1.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
15.5.1.1.1.10. Cardiovascular
Medicines
15.5.1.1.1.11. Dermatological
Medicines
15.5.1.1.1.12. Disinfectants
and Antiseptics
15.5.1.1.1.13. Gastrointestinal
Medicines
15.5.1.1.1.14. Endocrine
Disorders Medicines
15.5.1.1.1.15. Immunologicals
15.5.1.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
15.5.1.1.2. Devices/Equipment
15.5.1.1.2.1. In Vitro
Diagnostic (IVD) Devices
15.5.1.1.2.2. Diagnostic
Imaging Devices
15.5.1.1.2.3. Anesthesia and
Respiratory Care Devices
15.5.1.1.2.4. Cardiology
Devices
15.5.1.1.2.5. Orthopaedic Devices
15.5.1.1.2.6. Telemedicine
15.5.1.1.2.7. Monitoring
Devices
15.5.1.1.2.7.1. Blood Pressure
15.5.1.1.2.7.2. Pulse Oximetry
15.5.1.1.2.7.3. Temperature
Monitoring
15.5.1.1.2.7.4. Others
15.5.1.1.2.8. Others
15.5.1.1.3. Services
15.5.1.1.3.1. Pediatric
Surgical Services
15.5.1.1.3.2. Nursing Services
15.5.1.1.3.3. Pediatric Therapy
15.5.1.1.3.3.1. Speech Therapy
15.5.1.1.3.3.2. Physical
Therapy
15.5.1.1.3.3.3. Others
15.5.1.1.3.4. Others
15.5.1.2. Brazil Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1. Neonates (Below 28 days)
15.5.1.2.2. Infants (29 days to less than 2 years)
15.5.1.2.3. Children (2 years to less than 12 years)
15.5.1.2.4. Adolescents (12 years to less than 21 years)
15.5.1.3. Brazil Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.5.1.3.1. Online
15.5.1.3.2. Offline
15.5.1.3.2.1. Pharmacy and Drug
Stores
15.5.1.3.2.2. Specialty Stores
15.5.1.3.2.3. Hospitals and
Clinics
15.5.1.3.2.4. Others
15.5.2. Argentina
15.5.2.1. Argentina Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.2.1.1. Drugs
15.5.2.1.1.1. General
Anaesthetics and Oxygen
15.5.2.1.1.2. Pain and
Palliative Care
15.5.2.1.1.3. Antiallergics
15.5.2.1.1.4. Antidotes
15.5.2.1.1.5. Anticonvulsants/
Antiepileptics
15.5.2.1.1.6. Anti-Infective
Medicines
15.5.2.1.1.6.1. Anthelminthics
15.5.2.1.1.6.2. Antibacterials
15.5.2.1.1.6.3. Antifungal
Medicines
15.5.2.1.1.6.4. Antiviral
Medicines
15.5.2.1.1.6.5. Antiprotozoal
Medicines
15.5.2.1.1.6.6. Others
15.5.2.1.1.7. Antimigraine
Medicines
15.5.2.1.1.8. Immunomodulators
and Antineoplastics
15.5.2.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
15.5.2.1.1.10. Cardiovascular
Medicines
15.5.2.1.1.11. Dermatological
Medicines
15.5.2.1.1.12. Disinfectants
and Antiseptics
15.5.2.1.1.13. Gastrointestinal
Medicines
15.5.2.1.1.14. Endocrine
Disorders Medicines
15.5.2.1.1.15. Immunologicals
15.5.2.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
15.5.2.1.2. Devices/Equipment
15.5.2.1.2.1. In Vitro
Diagnostic (IVD) Devices
15.5.2.1.2.2. Diagnostic
Imaging Devices
15.5.2.1.2.3. Anesthesia and
Respiratory Care Devices
15.5.2.1.2.4. Cardiology
Devices
15.5.2.1.2.5. Orthopaedic Devices
15.5.2.1.2.6. Telemedicine
15.5.2.1.2.7. Monitoring
Devices
15.5.2.1.2.7.1. Blood Pressure
15.5.2.1.2.7.2. Pulse Oximetry
15.5.2.1.2.7.3. Temperature
Monitoring
15.5.2.1.2.7.4. Others
15.5.2.1.2.8. Others
15.5.2.1.3. Services
15.5.2.1.3.1. Pediatric
Surgical Services
15.5.2.1.3.2. Nursing Services
15.5.2.1.3.3. Pediatric Therapy
15.5.2.1.3.3.1. Speech Therapy
15.5.2.1.3.3.2. Physical
Therapy
15.5.2.1.3.3.3. Others
15.5.2.1.3.4. Others
15.5.2.2. Argentina Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1. Neonates (Below 28 days)
15.5.2.2.2. Infants (29 days to less than 2 years)
15.5.2.2.3. Children (2 years to less than 12 years)
15.5.2.2.4. Adolescents (12 years to less than 21 years)
15.5.2.3. Argentina Pediatric
Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.5.2.3.1. Online
15.5.2.3.2. Offline
15.5.2.3.2.1. Pharmacy and Drug
Stores
15.5.2.3.2.2. Specialty Stores
15.5.2.3.2.3. Hospitals and
Clinics
15.5.2.3.2.4. Others
15.5.3. Rest of Latin America
15.5.3.1. Rest of Latin America
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.3.1.1. Drugs
15.5.3.1.1.1. General
Anaesthetics and Oxygen
15.5.3.1.1.2. Pain and
Palliative Care
15.5.3.1.1.3. Antiallergics
15.5.3.1.1.4. Antidotes
15.5.3.1.1.5. Anticonvulsants/
Antiepileptics
15.5.3.1.1.6. Anti-Infective
Medicines
15.5.3.1.1.6.1. Anthelminthics
15.5.3.1.1.6.2. Antibacterials
15.5.3.1.1.6.3. Antifungal
Medicines
15.5.3.1.1.6.4. Antiviral
Medicines
15.5.3.1.1.6.5. Antiprotozoal
Medicines
15.5.3.1.1.6.6. Others
15.5.3.1.1.7. Antimigraine
Medicines
15.5.3.1.1.8. Immunomodulators
and Antineoplastics
15.5.3.1.1.9. Medicines
Affecting the Blood (Antianaemia Medicines, Coagulation, etc.)
15.5.3.1.1.10. Cardiovascular
Medicines
15.5.3.1.1.11. Dermatological
Medicines
15.5.3.1.1.12. Disinfectants
and Antiseptics
15.5.3.1.1.13. Gastrointestinal
Medicines
15.5.3.1.1.14. Endocrine
Disorders Medicines
15.5.3.1.1.15. Immunologicals
15.5.3.1.1.16. Others
(Diagnostic Agents, Respiratory Tract Medicines, Etc.)
15.5.3.1.2. Devices/Equipment
15.5.3.1.2.1. In Vitro
Diagnostic (IVD) Devices
15.5.3.1.2.2. Diagnostic
Imaging Devices
15.5.3.1.2.3. Anesthesia and
Respiratory Care Devices
15.5.3.1.2.4. Cardiology
Devices
15.5.3.1.2.5. Orthopaedic Devices
15.5.3.1.2.6. Telemedicine
15.5.3.1.2.7. Monitoring
Devices
15.5.3.1.2.7.1. Blood Pressure
15.5.3.1.2.7.2. Pulse Oximetry
15.5.3.1.2.7.3. Temperature
Monitoring
15.5.3.1.2.7.4. Others
15.5.3.1.2.8. Others
15.5.3.1.3. Services
15.5.3.1.3.1. Pediatric
Surgical Services
15.5.3.1.3.2. Nursing Services
15.5.3.1.3.3. Pediatric Therapy
15.5.3.1.3.3.1. Speech Therapy
15.5.3.1.3.3.2. Physical
Therapy
15.5.3.1.3.3.3. Others
15.5.3.1.3.4. Others
15.5.3.2. Rest of Latin America
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
15.5.3.2.1. Neonates (Below 28 days)
15.5.3.2.2. Infants (29 days to less than 2 years)
15.5.3.2.3. Children (2 years to less than 12 years)
15.5.3.2.4. Adolescents (12 years to less than 21 years)
15.5.3.3. Rest of Latin America
Pediatric Healthcare Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.5.3.3.1. Online
15.5.3.3.2. Offline
15.5.3.3.2.1. Pharmacy and Drug
Stores
15.5.3.3.2.2. Specialty Stores
15.5.3.3.2.3. Hospitals and
Clinics
15.5.3.3.2.4. Others
15.6. Key Segment for
Channeling Investments
15.6.1. By Country
15.6.2. By Offering
15.6.3. By Application
15.6.4. By Distribution Channel
16. Competitive Benchmarking
16.1. Brand Benchmarking
16.2. Market Share Analysis,
2018
16.3. Global Presence and
Growth Strategies
16.3.1. Mergers and
Acquisitions
16.3.2. Product Launches
16.3.3. Investments Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Allergan
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. Aveanna
Healthcare, LLC.
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business
Strategies
17.3. BAYADA
Home Health Care
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business
Strategies
17.4. Boehringer
Ingelheim International GmbH
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business
Strategies
17.5. Boston
Scientific Corporation
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business
Strategies
17.6. Cardinal
Health.
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business
Strategies
17.7. Eisai
Co., Ltd.
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business
Strategies
17.8. Epic
Health Services.
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7. Business
Strategies
17.9. GE
Healthcare (GENERAL ELECTRIC COMPANY)
17.9.1. Company Details
17.9.2. Company Overview
17.9.3. Product Offerings
17.9.4. Key Developments
17.9.5. Financial Analysis
17.9.6. SWOT Analysis
17.9.7. Business
Strategies
17.10. Gilead
Sciences, Inc.
17.10.1. Company Details
17.10.2. Company Overview
17.10.3. Product Offerings
17.10.4. Key Developments
17.10.5. Financial Analysis
17.10.6. SWOT Analysis
17.10.7. Business Strategies
17.11. GlaxoSmithKline
plc
17.11.1. Company Details
17.11.2. Company Overview
17.11.3. Product Offerings
17.11.4. Key Developments
17.11.5. Financial Analysis
17.11.6. SWOT Analysis
17.11.7. Business Strategies
17.12. Koninklijke
Philips N.V.,
17.12.1. Company Details
17.12.2. Company Overview
17.12.3. Product Offerings
17.12.4. Key Developments
17.12.5. Financial Analysis
17.12.6. SWOT Analysis
17.12.7. Business Strategies
17.13. Maksun
Biotech Pvt. Ltd.
17.13.1. Company Details
17.13.2. Company Overview
17.13.3. Product Offerings
17.13.4. Key Developments
17.13.5. Financial Analysis
17.13.6. SWOT Analysis
17.13.7. Business Strategies
17.14. Merck
& Co., Inc.
17.14.1. Company Details
17.14.2. Company Overview
17.14.3. Product Offerings
17.14.4. Key Developments
17.14.5. Financial Analysis
17.14.6. SWOT Analysis
17.14.7. Business Strategies
17.15. PAX
HEALTHCARE
17.15.1. Company Details
17.15.2. Company Overview
17.15.3. Product Offerings
17.15.4. Key Developments
17.15.5. Financial Analysis
17.15.6. SWOT Analysis
17.15.7. Business Strategies
17.16. Pediapharm
17.16.1. Company Details
17.16.2. Company Overview
17.16.3. Product Offerings
17.16.4. Key Developments
17.16.5. Financial Analysis
17.16.6. SWOT Analysis
17.16.7. Business Strategies
17.17. Sanofi
17.17.1. Company Details
17.17.2. Company Overview
17.17.3. Product Offerings
17.17.4. Key Developments
17.17.5. Financial Analysis
17.17.6. SWOT Analysis
17.17.7. Business Strategies
17.18. Siemens
Medical Solutions USA, Inc.
17.18.1. Company Details
17.18.2. Company Overview
17.18.3. Product Offerings
17.18.4. Key Developments
17.18.5. Financial Analysis
17.18.6. SWOT Analysis
17.18.7. Business Strategies
17.19. Stryker
17.19.1. Company Details
17.19.2. Company Overview
17.19.3. Product Offerings
17.19.4. Key Developments
17.19.5. Financial Analysis
17.19.6. SWOT Analysis
17.19.7. Business Strategies
17.20. Other Industry
Participants
Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
